CN118109480A - Early 15 gene and application thereof in regulating and controlling plant growth and development - Google Patents
Early 15 gene and application thereof in regulating and controlling plant growth and development Download PDFInfo
- Publication number
- CN118109480A CN118109480A CN202211529549.0A CN202211529549A CN118109480A CN 118109480 A CN118109480 A CN 118109480A CN 202211529549 A CN202211529549 A CN 202211529549A CN 118109480 A CN118109480 A CN 118109480A
- Authority
- CN
- China
- Prior art keywords
- plant
- early
- plants
- gene
- seq
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 230000001105 regulatory effect Effects 0.000 title claims abstract description 37
- 230000008635 plant growth Effects 0.000 title claims abstract description 23
- 238000011161 development Methods 0.000 title claims abstract description 17
- 230000008121 plant development Effects 0.000 title claims abstract description 15
- 101150029062 15 gene Proteins 0.000 title abstract description 13
- 230000001276 controlling effect Effects 0.000 title abstract description 6
- 241000196324 Embryophyta Species 0.000 claims abstract description 254
- 240000008042 Zea mays Species 0.000 claims abstract description 121
- 235000002017 Zea mays subsp mays Nutrition 0.000 claims abstract description 110
- 108090000623 proteins and genes Proteins 0.000 claims abstract description 90
- 235000016383 Zea mays subsp huehuetenangensis Nutrition 0.000 claims abstract description 68
- 235000009973 maize Nutrition 0.000 claims abstract description 68
- 235000005824 Zea mays ssp. parviglumis Nutrition 0.000 claims abstract description 42
- 235000005822 corn Nutrition 0.000 claims abstract description 42
- 102000004169 proteins and genes Human genes 0.000 claims abstract description 21
- 230000009261 transgenic effect Effects 0.000 claims description 128
- 239000002773 nucleotide Substances 0.000 claims description 65
- 125000003729 nucleotide group Chemical group 0.000 claims description 65
- 239000013598 vector Substances 0.000 claims description 49
- 150000007523 nucleic acids Chemical class 0.000 claims description 45
- 102000004196 processed proteins & peptides Human genes 0.000 claims description 45
- 108090000765 processed proteins & peptides Proteins 0.000 claims description 45
- 229920001184 polypeptide Polymers 0.000 claims description 44
- 102000039446 nucleic acids Human genes 0.000 claims description 42
- 108020004707 nucleic acids Proteins 0.000 claims description 42
- 238000000034 method Methods 0.000 claims description 31
- 125000003275 alpha amino acid group Chemical group 0.000 claims description 29
- 238000010362 genome editing Methods 0.000 claims description 26
- 240000007594 Oryza sativa Species 0.000 claims description 18
- 235000007164 Oryza sativa Nutrition 0.000 claims description 18
- 235000009566 rice Nutrition 0.000 claims description 17
- 235000014698 Brassica juncea var multisecta Nutrition 0.000 claims description 16
- 235000006008 Brassica napus var napus Nutrition 0.000 claims description 16
- 235000006618 Brassica rapa subsp oleifera Nutrition 0.000 claims description 16
- 235000004977 Brassica sinapistrum Nutrition 0.000 claims description 16
- 125000000539 amino acid group Chemical group 0.000 claims description 14
- 238000010453 CRISPR/Cas method Methods 0.000 claims description 11
- 244000062793 Sorghum vulgare Species 0.000 claims description 11
- 238000006467 substitution reaction Methods 0.000 claims description 11
- 241000219194 Arabidopsis Species 0.000 claims description 9
- 244000105624 Arachis hypogaea Species 0.000 claims description 9
- 235000010777 Arachis hypogaea Nutrition 0.000 claims description 9
- 244000075850 Avena orientalis Species 0.000 claims description 9
- 235000007319 Avena orientalis Nutrition 0.000 claims description 9
- 240000007124 Brassica oleracea Species 0.000 claims description 9
- 235000010469 Glycine max Nutrition 0.000 claims description 9
- 244000068988 Glycine max Species 0.000 claims description 9
- 244000020551 Helianthus annuus Species 0.000 claims description 9
- 235000003222 Helianthus annuus Nutrition 0.000 claims description 9
- 240000005979 Hordeum vulgare Species 0.000 claims description 9
- 235000007340 Hordeum vulgare Nutrition 0.000 claims description 9
- 235000007688 Lycopersicon esculentum Nutrition 0.000 claims description 9
- 240000003183 Manihot esculenta Species 0.000 claims description 9
- 235000002637 Nicotiana tabacum Nutrition 0.000 claims description 9
- 244000061176 Nicotiana tabacum Species 0.000 claims description 9
- 235000007238 Secale cereale Nutrition 0.000 claims description 9
- 244000082988 Secale cereale Species 0.000 claims description 9
- 240000003768 Solanum lycopersicum Species 0.000 claims description 9
- 235000002595 Solanum tuberosum Nutrition 0.000 claims description 9
- 244000061456 Solanum tuberosum Species 0.000 claims description 9
- 235000011684 Sorghum saccharatum Nutrition 0.000 claims description 9
- 235000021307 Triticum Nutrition 0.000 claims description 9
- 241000219195 Arabidopsis thaliana Species 0.000 claims description 8
- 235000017060 Arachis glabrata Nutrition 0.000 claims description 8
- 235000018262 Arachis monticola Nutrition 0.000 claims description 8
- 241000219310 Beta vulgaris subsp. vulgaris Species 0.000 claims description 8
- 241000219198 Brassica Species 0.000 claims description 8
- 235000003351 Brassica cretica Nutrition 0.000 claims description 8
- 235000003899 Brassica oleracea var acephala Nutrition 0.000 claims description 8
- 235000011301 Brassica oleracea var capitata Nutrition 0.000 claims description 8
- 235000001169 Brassica oleracea var oleracea Nutrition 0.000 claims description 8
- 235000003343 Brassica rupestris Nutrition 0.000 claims description 8
- 229920000742 Cotton Polymers 0.000 claims description 8
- 235000002678 Ipomoea batatas Nutrition 0.000 claims description 8
- 244000017020 Ipomoea batatas Species 0.000 claims description 8
- 235000016735 Manihot esculenta subsp esculenta Nutrition 0.000 claims description 8
- 240000000111 Saccharum officinarum Species 0.000 claims description 8
- 235000007201 Saccharum officinarum Nutrition 0.000 claims description 8
- 235000021536 Sugar beet Nutrition 0.000 claims description 8
- QKSKPIVNLNLAAV-UHFFFAOYSA-N bis(2-chloroethyl) sulfide Chemical compound ClCCSCCCl QKSKPIVNLNLAAV-UHFFFAOYSA-N 0.000 claims description 8
- 235000019713 millet Nutrition 0.000 claims description 8
- 235000010460 mustard Nutrition 0.000 claims description 8
- 235000020232 peanut Nutrition 0.000 claims description 8
- 230000001488 breeding effect Effects 0.000 claims description 7
- 238000012217 deletion Methods 0.000 claims description 7
- 230000037430 deletion Effects 0.000 claims description 7
- 235000007558 Avena sp Nutrition 0.000 claims description 6
- 238000009395 breeding Methods 0.000 claims description 6
- 244000038559 crop plants Species 0.000 claims description 5
- 244000098338 Triticum aestivum Species 0.000 claims description 4
- 238000010459 TALEN Methods 0.000 claims description 2
- 108010043645 Transcription Activator-Like Effector Nucleases Proteins 0.000 claims description 2
- 240000000385 Brassica napus var. napus Species 0.000 claims 6
- 244000299507 Gossypium hirsutum Species 0.000 claims 3
- 210000004027 cell Anatomy 0.000 description 36
- 108020004414 DNA Proteins 0.000 description 26
- 238000012360 testing method Methods 0.000 description 21
- 235000001014 amino acid Nutrition 0.000 description 20
- 229940024606 amino acid Drugs 0.000 description 19
- 150000001413 amino acids Chemical class 0.000 description 19
- 238000004458 analytical method Methods 0.000 description 18
- 239000000463 material Substances 0.000 description 18
- 235000018102 proteins Nutrition 0.000 description 18
- 230000017260 vegetative to reproductive phase transition of meristem Effects 0.000 description 18
- 230000002829 reductive effect Effects 0.000 description 17
- 239000013604 expression vector Substances 0.000 description 13
- 230000014509 gene expression Effects 0.000 description 13
- 238000001061 Dunnett's test Methods 0.000 description 12
- 108091032973 (ribonucleotides)n+m Proteins 0.000 description 10
- 241001301148 Brassica rapa subsp. oleifera Species 0.000 description 10
- 238000003259 recombinant expression Methods 0.000 description 10
- 238000012163 sequencing technique Methods 0.000 description 10
- 238000009331 sowing Methods 0.000 description 10
- 230000006870 function Effects 0.000 description 9
- 238000009396 hybridization Methods 0.000 description 9
- 238000003752 polymerase chain reaction Methods 0.000 description 9
- 241000589158 Agrobacterium Species 0.000 description 8
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 8
- 238000010276 construction Methods 0.000 description 8
- 230000002018 overexpression Effects 0.000 description 8
- 239000000843 powder Substances 0.000 description 8
- 241000894006 Bacteria Species 0.000 description 7
- 240000006394 Sorghum bicolor Species 0.000 description 7
- 235000007244 Zea mays Nutrition 0.000 description 7
- 230000012010 growth Effects 0.000 description 7
- 239000013612 plasmid Substances 0.000 description 7
- ZHNUHDYFZUAESO-UHFFFAOYSA-N Formamide Chemical compound NC=O ZHNUHDYFZUAESO-UHFFFAOYSA-N 0.000 description 6
- 108091028043 Nucleic acid sequence Proteins 0.000 description 6
- 238000012408 PCR amplification Methods 0.000 description 6
- 241000209140 Triticum Species 0.000 description 6
- 239000002299 complementary DNA Substances 0.000 description 6
- 230000003111 delayed effect Effects 0.000 description 6
- 238000013461 design Methods 0.000 description 6
- 239000012634 fragment Substances 0.000 description 6
- 108090000790 Enzymes Proteins 0.000 description 5
- 102000004190 Enzymes Human genes 0.000 description 5
- 241000219146 Gossypium Species 0.000 description 5
- 108091023040 Transcription factor Proteins 0.000 description 5
- 102000040945 Transcription factor Human genes 0.000 description 5
- 238000003780 insertion Methods 0.000 description 5
- 230000037431 insertion Effects 0.000 description 5
- 238000012795 verification Methods 0.000 description 5
- 108700028369 Alleles Proteins 0.000 description 4
- 102000053602 DNA Human genes 0.000 description 4
- DHMQDGOQFOQNFH-UHFFFAOYSA-N Glycine Chemical compound NCC(O)=O DHMQDGOQFOQNFH-UHFFFAOYSA-N 0.000 description 4
- 238000001514 detection method Methods 0.000 description 4
- 238000002474 experimental method Methods 0.000 description 4
- 230000035800 maturation Effects 0.000 description 4
- 230000001404 mediated effect Effects 0.000 description 4
- 235000013336 milk Nutrition 0.000 description 4
- 239000008267 milk Substances 0.000 description 4
- 210000004080 milk Anatomy 0.000 description 4
- 238000003753 real-time PCR Methods 0.000 description 4
- 150000003839 salts Chemical class 0.000 description 4
- 238000012216 screening Methods 0.000 description 4
- 239000011780 sodium chloride Substances 0.000 description 4
- 238000013518 transcription Methods 0.000 description 4
- 230000035897 transcription Effects 0.000 description 4
- 230000002103 transcriptional effect Effects 0.000 description 4
- 239000013603 viral vector Substances 0.000 description 4
- 241000589155 Agrobacterium tumefaciens Species 0.000 description 3
- 239000004475 Arginine Substances 0.000 description 3
- 108091033409 CRISPR Proteins 0.000 description 3
- 241001057636 Dracaena deremensis Species 0.000 description 3
- 241000588724 Escherichia coli Species 0.000 description 3
- 206010020649 Hyperkeratosis Diseases 0.000 description 3
- QNAYBMKLOCPYGJ-REOHCLBHSA-N L-alanine Chemical compound C[C@H](N)C(O)=O QNAYBMKLOCPYGJ-REOHCLBHSA-N 0.000 description 3
- KZSNJWFQEVHDMF-BYPYZUCNSA-N L-valine Chemical compound CC(C)[C@H](N)C(O)=O KZSNJWFQEVHDMF-BYPYZUCNSA-N 0.000 description 3
- 108091026898 Leader sequence (mRNA) Proteins 0.000 description 3
- 241000209510 Liliopsida Species 0.000 description 3
- 108091034117 Oligonucleotide Proteins 0.000 description 3
- 108020004511 Recombinant DNA Proteins 0.000 description 3
- KZSNJWFQEVHDMF-UHFFFAOYSA-N Valine Natural products CC(C)C(N)C(O)=O KZSNJWFQEVHDMF-UHFFFAOYSA-N 0.000 description 3
- 235000004279 alanine Nutrition 0.000 description 3
- 230000003321 amplification Effects 0.000 description 3
- 230000000295 complement effect Effects 0.000 description 3
- 239000006185 dispersion Substances 0.000 description 3
- 241001233957 eudicotyledons Species 0.000 description 3
- 230000002068 genetic effect Effects 0.000 description 3
- 238000003306 harvesting Methods 0.000 description 3
- 229960000310 isoleucine Drugs 0.000 description 3
- 238000004519 manufacturing process Methods 0.000 description 3
- 238000003199 nucleic acid amplification method Methods 0.000 description 3
- 238000012545 processing Methods 0.000 description 3
- 230000005070 ripening Effects 0.000 description 3
- 210000001519 tissue Anatomy 0.000 description 3
- 239000004474 valine Substances 0.000 description 3
- MTCFGRXMJLQNBG-REOHCLBHSA-N (2S)-2-Amino-3-hydroxypropansäure Chemical compound OC[C@H](N)C(O)=O MTCFGRXMJLQNBG-REOHCLBHSA-N 0.000 description 2
- 101150063778 AGL12 gene Proteins 0.000 description 2
- DCXYFEDJOCDNAF-UHFFFAOYSA-N Asparagine Natural products OC(=O)C(N)CC(N)=O DCXYFEDJOCDNAF-UHFFFAOYSA-N 0.000 description 2
- 208000003643 Callosities Diseases 0.000 description 2
- 241000218631 Coniferophyta Species 0.000 description 2
- 239000004471 Glycine Substances 0.000 description 2
- 240000000047 Gossypium barbadense Species 0.000 description 2
- 235000009429 Gossypium barbadense Nutrition 0.000 description 2
- XUJNEKJLAYXESH-REOHCLBHSA-N L-Cysteine Chemical compound SC[C@H](N)C(O)=O XUJNEKJLAYXESH-REOHCLBHSA-N 0.000 description 2
- ODKSFYDXXFIFQN-BYPYZUCNSA-P L-argininium(2+) Chemical compound NC(=[NH2+])NCCC[C@H]([NH3+])C(O)=O ODKSFYDXXFIFQN-BYPYZUCNSA-P 0.000 description 2
- DCXYFEDJOCDNAF-REOHCLBHSA-N L-asparagine Chemical compound OC(=O)[C@@H](N)CC(N)=O DCXYFEDJOCDNAF-REOHCLBHSA-N 0.000 description 2
- ZDXPYRJPNDTMRX-VKHMYHEASA-N L-glutamine Chemical compound OC(=O)[C@@H](N)CCC(N)=O ZDXPYRJPNDTMRX-VKHMYHEASA-N 0.000 description 2
- HNDVDQJCIGZPNO-YFKPBYRVSA-N L-histidine Chemical compound OC(=O)[C@@H](N)CC1=CN=CN1 HNDVDQJCIGZPNO-YFKPBYRVSA-N 0.000 description 2
- AGPKZVBTJJNPAG-WHFBIAKZSA-N L-isoleucine Chemical compound CC[C@H](C)[C@H](N)C(O)=O AGPKZVBTJJNPAG-WHFBIAKZSA-N 0.000 description 2
- ROHFNLRQFUQHCH-YFKPBYRVSA-N L-leucine Chemical compound CC(C)C[C@H](N)C(O)=O ROHFNLRQFUQHCH-YFKPBYRVSA-N 0.000 description 2
- KDXKERNSBIXSRK-YFKPBYRVSA-N L-lysine Chemical compound NCCCC[C@H](N)C(O)=O KDXKERNSBIXSRK-YFKPBYRVSA-N 0.000 description 2
- FFEARJCKVFRZRR-BYPYZUCNSA-N L-methionine Chemical compound CSCC[C@H](N)C(O)=O FFEARJCKVFRZRR-BYPYZUCNSA-N 0.000 description 2
- COLNVLDHVKWLRT-QMMMGPOBSA-N L-phenylalanine Chemical compound OC(=O)[C@@H](N)CC1=CC=CC=C1 COLNVLDHVKWLRT-QMMMGPOBSA-N 0.000 description 2
- AYFVYJQAPQTCCC-GBXIJSLDSA-N L-threonine Chemical compound C[C@@H](O)[C@H](N)C(O)=O AYFVYJQAPQTCCC-GBXIJSLDSA-N 0.000 description 2
- QIVBCDIJIAJPQS-VIFPVBQESA-N L-tryptophane Chemical compound C1=CC=C2C(C[C@H](N)C(O)=O)=CNC2=C1 QIVBCDIJIAJPQS-VIFPVBQESA-N 0.000 description 2
- OUYCCCASQSFEME-QMMMGPOBSA-N L-tyrosine Chemical compound OC(=O)[C@@H](N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-QMMMGPOBSA-N 0.000 description 2
- ROHFNLRQFUQHCH-UHFFFAOYSA-N Leucine Natural products CC(C)CC(N)C(O)=O ROHFNLRQFUQHCH-UHFFFAOYSA-N 0.000 description 2
- KDXKERNSBIXSRK-UHFFFAOYSA-N Lysine Natural products NCCCCC(N)C(O)=O KDXKERNSBIXSRK-UHFFFAOYSA-N 0.000 description 2
- 239000004472 Lysine Substances 0.000 description 2
- 101710141828 MADS-box transcription factor 14 Proteins 0.000 description 2
- 235000007195 Pennisetum typhoides Nutrition 0.000 description 2
- 238000010802 RNA extraction kit Methods 0.000 description 2
- MTCFGRXMJLQNBG-UHFFFAOYSA-N Serine Natural products OCC(N)C(O)=O MTCFGRXMJLQNBG-UHFFFAOYSA-N 0.000 description 2
- AYFVYJQAPQTCCC-UHFFFAOYSA-N Threonine Natural products CC(O)C(N)C(O)=O AYFVYJQAPQTCCC-UHFFFAOYSA-N 0.000 description 2
- 239000004473 Threonine Substances 0.000 description 2
- 108700019146 Transgenes Proteins 0.000 description 2
- QIVBCDIJIAJPQS-UHFFFAOYSA-N Tryptophan Natural products C1=CC=C2C(CC(N)C(O)=O)=CNC2=C1 QIVBCDIJIAJPQS-UHFFFAOYSA-N 0.000 description 2
- 238000000246 agarose gel electrophoresis Methods 0.000 description 2
- ODKSFYDXXFIFQN-UHFFFAOYSA-N arginine Natural products OC(=O)C(N)CCCNC(N)=N ODKSFYDXXFIFQN-UHFFFAOYSA-N 0.000 description 2
- 235000009582 asparagine Nutrition 0.000 description 2
- 229960001230 asparagine Drugs 0.000 description 2
- 101150103518 bar gene Proteins 0.000 description 2
- 239000011324 bead Substances 0.000 description 2
- 230000008827 biological function Effects 0.000 description 2
- 210000004899 c-terminal region Anatomy 0.000 description 2
- 235000013339 cereals Nutrition 0.000 description 2
- 238000006243 chemical reaction Methods 0.000 description 2
- 235000018417 cysteine Nutrition 0.000 description 2
- XUJNEKJLAYXESH-UHFFFAOYSA-N cysteine Natural products SCC(N)C(O)=O XUJNEKJLAYXESH-UHFFFAOYSA-N 0.000 description 2
- 230000001934 delay Effects 0.000 description 2
- 239000005547 deoxyribonucleotide Substances 0.000 description 2
- 125000002637 deoxyribonucleotide group Chemical group 0.000 description 2
- 230000018109 developmental process Effects 0.000 description 2
- 210000005069 ears Anatomy 0.000 description 2
- 230000000694 effects Effects 0.000 description 2
- 238000005516 engineering process Methods 0.000 description 2
- 238000003208 gene overexpression Methods 0.000 description 2
- ZDXPYRJPNDTMRX-UHFFFAOYSA-N glutamine Natural products OC(=O)C(N)CCC(N)=O ZDXPYRJPNDTMRX-UHFFFAOYSA-N 0.000 description 2
- 238000010842 high-capacity cDNA reverse transcription kit Methods 0.000 description 2
- HNDVDQJCIGZPNO-UHFFFAOYSA-N histidine Natural products OC(=O)C(N)CC1=CN=CN1 HNDVDQJCIGZPNO-UHFFFAOYSA-N 0.000 description 2
- 230000009878 intermolecular interaction Effects 0.000 description 2
- AGPKZVBTJJNPAG-UHFFFAOYSA-N isoleucine Natural products CCC(C)C(N)C(O)=O AGPKZVBTJJNPAG-UHFFFAOYSA-N 0.000 description 2
- 229930182817 methionine Natural products 0.000 description 2
- 230000007935 neutral effect Effects 0.000 description 2
- 238000007899 nucleic acid hybridization Methods 0.000 description 2
- COLNVLDHVKWLRT-UHFFFAOYSA-N phenylalanine Natural products OC(=O)C(N)CC1=CC=CC=C1 COLNVLDHVKWLRT-UHFFFAOYSA-N 0.000 description 2
- 229920000642 polymer Polymers 0.000 description 2
- 102000040430 polynucleotide Human genes 0.000 description 2
- 108091033319 polynucleotide Proteins 0.000 description 2
- 239000002157 polynucleotide Substances 0.000 description 2
- 230000008569 process Effects 0.000 description 2
- 230000001737 promoting effect Effects 0.000 description 2
- 210000001938 protoplast Anatomy 0.000 description 2
- 230000010076 replication Effects 0.000 description 2
- 108091008146 restriction endonucleases Proteins 0.000 description 2
- 230000002441 reversible effect Effects 0.000 description 2
- 239000000523 sample Substances 0.000 description 2
- 230000001131 transforming effect Effects 0.000 description 2
- OUYCCCASQSFEME-UHFFFAOYSA-N tyrosine Natural products OC(=O)C(N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-UHFFFAOYSA-N 0.000 description 2
- 238000011144 upstream manufacturing Methods 0.000 description 2
- 238000005406 washing Methods 0.000 description 2
- BEJKOYIMCGMNRB-GRHHLOCNSA-N (2s)-2-amino-3-(4-hydroxyphenyl)propanoic acid;(2s)-2-amino-3-phenylpropanoic acid Chemical compound OC(=O)[C@@H](N)CC1=CC=CC=C1.OC(=O)[C@@H](N)CC1=CC=C(O)C=C1 BEJKOYIMCGMNRB-GRHHLOCNSA-N 0.000 description 1
- PSLCKQYQNVNTQI-BHFSHLQUSA-N (2s)-2-aminobutanedioic acid;(2s)-2-aminopentanedioic acid Chemical compound OC(=O)[C@@H](N)CC(O)=O.OC(=O)[C@@H](N)CCC(O)=O PSLCKQYQNVNTQI-BHFSHLQUSA-N 0.000 description 1
- 101150084750 1 gene Proteins 0.000 description 1
- 101150090724 3 gene Proteins 0.000 description 1
- FWMNVWWHGCHHJJ-SKKKGAJSSA-N 4-amino-1-[(2r)-6-amino-2-[[(2r)-2-[[(2r)-2-[[(2r)-2-amino-3-phenylpropanoyl]amino]-3-phenylpropanoyl]amino]-4-methylpentanoyl]amino]hexanoyl]piperidine-4-carboxylic acid Chemical compound C([C@H](C(=O)N[C@H](CC(C)C)C(=O)N[C@H](CCCCN)C(=O)N1CCC(N)(CC1)C(O)=O)NC(=O)[C@H](N)CC=1C=CC=CC=1)C1=CC=CC=C1 FWMNVWWHGCHHJJ-SKKKGAJSSA-N 0.000 description 1
- 241001164825 Adeno-associated virus - 8 Species 0.000 description 1
- 101100215675 Arabidopsis thaliana AGL12 gene Proteins 0.000 description 1
- 101100378605 Arabidopsis thaliana AGL28 gene Proteins 0.000 description 1
- 235000011303 Brassica alboglabra Nutrition 0.000 description 1
- 244000060924 Brassica campestris Species 0.000 description 1
- 235000005637 Brassica campestris Nutrition 0.000 description 1
- 244000178993 Brassica juncea Species 0.000 description 1
- 235000011332 Brassica juncea Nutrition 0.000 description 1
- 235000014700 Brassica juncea var napiformis Nutrition 0.000 description 1
- 240000002791 Brassica napus Species 0.000 description 1
- 235000011293 Brassica napus Nutrition 0.000 description 1
- 235000011302 Brassica oleracea Nutrition 0.000 description 1
- 241000195940 Bryophyta Species 0.000 description 1
- 108091026890 Coding region Proteins 0.000 description 1
- 108020004705 Codon Proteins 0.000 description 1
- 241000195493 Cryptophyta Species 0.000 description 1
- 230000004568 DNA-binding Effects 0.000 description 1
- 102000004163 DNA-directed RNA polymerases Human genes 0.000 description 1
- 108090000626 DNA-directed RNA polymerases Proteins 0.000 description 1
- 241000702421 Dependoparvovirus Species 0.000 description 1
- 241000195955 Equisetum hyemale Species 0.000 description 1
- 241000233866 Fungi Species 0.000 description 1
- 108700039691 Genetic Promoter Regions Proteins 0.000 description 1
- WHUUTDBJXJRKMK-UHFFFAOYSA-N Glutamic acid Natural products OC(=O)C(N)CCC(O)=O WHUUTDBJXJRKMK-UHFFFAOYSA-N 0.000 description 1
- 108020005004 Guide RNA Proteins 0.000 description 1
- 208000009889 Herpes Simplex Diseases 0.000 description 1
- 241000238631 Hexapoda Species 0.000 description 1
- 108091092195 Intron Proteins 0.000 description 1
- 235000021506 Ipomoea Nutrition 0.000 description 1
- 241000207783 Ipomoea Species 0.000 description 1
- ONIBWKKTOPOVIA-BYPYZUCNSA-N L-Proline Chemical compound OC(=O)[C@@H]1CCCN1 ONIBWKKTOPOVIA-BYPYZUCNSA-N 0.000 description 1
- CKLJMWTZIZZHCS-REOHCLBHSA-N L-aspartic acid Chemical compound OC(=O)[C@@H](N)CC(O)=O CKLJMWTZIZZHCS-REOHCLBHSA-N 0.000 description 1
- WHUUTDBJXJRKMK-VKHMYHEASA-N L-glutamic acid Chemical compound OC(=O)[C@@H](N)CCC(O)=O WHUUTDBJXJRKMK-VKHMYHEASA-N 0.000 description 1
- 108700005090 Lethal Genes Proteins 0.000 description 1
- 101150014737 MADS1 gene Proteins 0.000 description 1
- 241000218922 Magnoliophyta Species 0.000 description 1
- 235000004456 Manihot esculenta Nutrition 0.000 description 1
- 108091027974 Mature messenger RNA Proteins 0.000 description 1
- 108020005196 Mitochondrial DNA Proteins 0.000 description 1
- 102000015636 Oligopeptides Human genes 0.000 description 1
- 108010038807 Oligopeptides Chemical class 0.000 description 1
- 101000962493 Oryza sativa subsp. japonica MADS-box transcription factor 15 Proteins 0.000 description 1
- 244000038248 Pennisetum spicatum Species 0.000 description 1
- 244000115721 Pennisetum typhoides Species 0.000 description 1
- 235000005205 Pinus Nutrition 0.000 description 1
- 241000218602 Pinus <genus> Species 0.000 description 1
- 241000985694 Polypodiopsida Species 0.000 description 1
- ONIBWKKTOPOVIA-UHFFFAOYSA-N Proline Natural products OC(=O)C1CCCN1 ONIBWKKTOPOVIA-UHFFFAOYSA-N 0.000 description 1
- 102000009572 RNA Polymerase II Human genes 0.000 description 1
- 108010009460 RNA Polymerase II Proteins 0.000 description 1
- 238000012228 RNA interference-mediated gene silencing Methods 0.000 description 1
- 230000004570 RNA-binding Effects 0.000 description 1
- 108700005075 Regulator Genes Proteins 0.000 description 1
- 108700008625 Reporter Genes Proteins 0.000 description 1
- 108091028664 Ribonucleotide Proteins 0.000 description 1
- 240000004808 Saccharomyces cerevisiae Species 0.000 description 1
- 241000209051 Saccharum Species 0.000 description 1
- 235000008515 Setaria glauca Nutrition 0.000 description 1
- 235000007230 Sorghum bicolor Nutrition 0.000 description 1
- 229920002472 Starch Polymers 0.000 description 1
- NINIDFKCEFEMDL-UHFFFAOYSA-N Sulfur Chemical compound [S] NINIDFKCEFEMDL-UHFFFAOYSA-N 0.000 description 1
- 108091036066 Three prime untranslated region Proteins 0.000 description 1
- 241000700618 Vaccinia virus Species 0.000 description 1
- 241000700605 Viruses Species 0.000 description 1
- 230000002378 acidificating effect Effects 0.000 description 1
- 230000009471 action Effects 0.000 description 1
- 230000004913 activation Effects 0.000 description 1
- 125000001931 aliphatic group Chemical group 0.000 description 1
- 150000001408 amides Chemical class 0.000 description 1
- 210000004102 animal cell Anatomy 0.000 description 1
- 238000000137 annealing Methods 0.000 description 1
- 238000013459 approach Methods 0.000 description 1
- 125000003118 aryl group Chemical group 0.000 description 1
- 235000003704 aspartic acid Nutrition 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- OQFSQFPPLPISGP-UHFFFAOYSA-N beta-carboxyaspartic acid Natural products OC(=O)C(N)C(C(O)=O)C(O)=O OQFSQFPPLPISGP-UHFFFAOYSA-N 0.000 description 1
- 238000002306 biochemical method Methods 0.000 description 1
- 238000003766 bioinformatics method Methods 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 101150038500 cas9 gene Proteins 0.000 description 1
- 101150102092 ccdB gene Proteins 0.000 description 1
- 230000004663 cell proliferation Effects 0.000 description 1
- 230000001413 cellular effect Effects 0.000 description 1
- 238000007385 chemical modification Methods 0.000 description 1
- 230000002759 chromosomal effect Effects 0.000 description 1
- 210000000349 chromosome Anatomy 0.000 description 1
- 238000010367 cloning Methods 0.000 description 1
- 150000001875 compounds Chemical class 0.000 description 1
- 230000034431 double-strand break repair via homologous recombination Effects 0.000 description 1
- 230000003828 downregulation Effects 0.000 description 1
- 241001493065 dsRNA viruses Species 0.000 description 1
- 235000013399 edible fruits Nutrition 0.000 description 1
- 238000004520 electroporation Methods 0.000 description 1
- 210000002257 embryonic structure Anatomy 0.000 description 1
- 238000001976 enzyme digestion Methods 0.000 description 1
- 210000003527 eukaryotic cell Anatomy 0.000 description 1
- 210000001808 exosome Anatomy 0.000 description 1
- 230000008124 floral development Effects 0.000 description 1
- 238000010230 functional analysis Methods 0.000 description 1
- 230000004927 fusion Effects 0.000 description 1
- 238000003633 gene expression assay Methods 0.000 description 1
- 238000003209 gene knockout Methods 0.000 description 1
- 230000009368 gene silencing by RNA Effects 0.000 description 1
- 235000013922 glutamic acid Nutrition 0.000 description 1
- 239000004220 glutamic acid Substances 0.000 description 1
- 238000000227 grinding Methods 0.000 description 1
- 230000002363 herbicidal effect Effects 0.000 description 1
- 239000004009 herbicide Substances 0.000 description 1
- 230000002209 hydrophobic effect Effects 0.000 description 1
- 101150062015 hyg gene Proteins 0.000 description 1
- 230000001939 inductive effect Effects 0.000 description 1
- 230000002401 inhibitory effect Effects 0.000 description 1
- 239000002502 liposome Substances 0.000 description 1
- 230000004807 localization Effects 0.000 description 1
- 229920002521 macromolecule Polymers 0.000 description 1
- 239000003550 marker Substances 0.000 description 1
- 235000012054 meals Nutrition 0.000 description 1
- 230000000442 meristematic effect Effects 0.000 description 1
- 230000004060 metabolic process Effects 0.000 description 1
- 239000002207 metabolite Substances 0.000 description 1
- 238000002493 microarray Methods 0.000 description 1
- 238000000520 microinjection Methods 0.000 description 1
- 230000000877 morphologic effect Effects 0.000 description 1
- 230000035772 mutation Effects 0.000 description 1
- 239000002105 nanoparticle Substances 0.000 description 1
- 239000013642 negative control Substances 0.000 description 1
- 238000006384 oligomerization reaction Methods 0.000 description 1
- 210000000056 organ Anatomy 0.000 description 1
- 210000003463 organelle Anatomy 0.000 description 1
- 230000036961 partial effect Effects 0.000 description 1
- 239000002245 particle Substances 0.000 description 1
- 230000035790 physiological processes and functions Effects 0.000 description 1
- 238000003976 plant breeding Methods 0.000 description 1
- 230000008638 plant developmental process Effects 0.000 description 1
- 210000002706 plastid Anatomy 0.000 description 1
- 239000013641 positive control Substances 0.000 description 1
- 230000001124 posttranscriptional effect Effects 0.000 description 1
- 238000002360 preparation method Methods 0.000 description 1
- 210000001236 prokaryotic cell Anatomy 0.000 description 1
- 238000001742 protein purification Methods 0.000 description 1
- 230000004850 protein–protein interaction Effects 0.000 description 1
- 238000010188 recombinant method Methods 0.000 description 1
- 230000004044 response Effects 0.000 description 1
- 230000001177 retroviral effect Effects 0.000 description 1
- 238000003757 reverse transcription PCR Methods 0.000 description 1
- 239000002336 ribonucleotide Substances 0.000 description 1
- 125000002652 ribonucleotide group Chemical group 0.000 description 1
- NLJMYIDDQXHKNR-UHFFFAOYSA-K sodium citrate Chemical compound O.O.[Na+].[Na+].[Na+].[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O NLJMYIDDQXHKNR-UHFFFAOYSA-K 0.000 description 1
- 239000001509 sodium citrate Substances 0.000 description 1
- 238000010561 standard procedure Methods 0.000 description 1
- 235000019698 starch Nutrition 0.000 description 1
- 239000008107 starch Substances 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 239000011593 sulfur Substances 0.000 description 1
- 229910052717 sulfur Inorganic materials 0.000 description 1
- 238000003786 synthesis reaction Methods 0.000 description 1
- 230000002194 synthesizing effect Effects 0.000 description 1
- 238000007862 touchdown PCR Methods 0.000 description 1
- 230000002463 transducing effect Effects 0.000 description 1
- 230000009466 transformation Effects 0.000 description 1
- 230000007704 transition Effects 0.000 description 1
- 241000701161 unidentified adenovirus Species 0.000 description 1
- 241000701447 unidentified baculovirus Species 0.000 description 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 1
Landscapes
- Breeding Of Plants And Reproduction By Means Of Culturing (AREA)
Abstract
The invention discloses an early 15 gene, a coded protein thereof and application thereof in regulating and controlling plant growth and development, in particular to regulating and controlling early maturing and dwarf of corn. The present invention demonstrates that early maturing and dwarf plants, particularly maize plants, can be obtained by over-expressing the "early 15" gene in plants, particularly maize.
Description
Technical Field
The invention relates to an early 15 gene, a coded protein thereof and application thereof in regulating and controlling plant growth and development, in particular to regulating and controlling early maturing and dwarf of corn.
Background
Corn occupies a serious position in the grain production in China and even worldwide. Early maturing, dwarf and density resistance are the directions of corn breeding. On one hand, the corn planting area can be enlarged, so that the corn planting area can be used as a spring sowing area in the cold area in the north and in the cold area in one season; on the other hand, the early maturing can lead the corn to be planted in the suitable sowing area in a repeated sowing way. In order to ensure that the corn rotation area of Huang-Huai-Hai wheat is two seasons in one year, the growth period of corn cannot be too long, and the genes with shortened growth period can enable varieties which are too long in growth period and are not suitable for being planted in Huang-Huai-Hai to become suitable for being planted in Huang-Huai-Hai summer. In addition, the early ripening is more suitable for mechanical operation, because the moisture content of the corn kernels is reduced by less than 25% before harvesting after the corn is ripe, and the direct harvesting of the kernels can lead to the increase of the kernel breaking rate of the corn kernels, which is not beneficial to mechanical harvesting. The corn dwarf can increase planting density, enhance lodging resistance and improve yield.
The transcription factor coded by MADS-box family gene plays a very important role in ABCDE model of plant flower development, and also participates in regulating other links in plant development process, such as growth of vegetative organ, etc. AGL12 (Tapia-Lopez et al, 2008) and AGL28 (Yoo et al, 2006) in Arabidopsis are related to flowering time of plants. OsMADS14 in rice is a regulator mainly responsible for early flowering of rice, and overexpression of OsMADS14 gene in rice can severely shorten the heading stage of rice and form an extremely early flowering phenotype (Pelucchi et al., 2002). The gene OsMADS15 regulating rice flowering downstream, the overexpression of which can lead to the elongation of transgenic rice internodes, the plant becoming shorter and flowering being advanced (Lu et al 2012). Overexpression of ZmMADS1 in maize resulted in an early flowering phenotype, and RNA interference mediated down-regulation of ZmMADS1 resulted in maize flowering delay (Alter et al, 2016). Unlike the ZmMADS1 sequence reported by Alter from maize inbred B73, the "early 15" gene encoding MADS-box transcription factor MADS1 is also derived from maize inbred Zheng 58, and there is 8 point differences in CDS sequence and 5 point differences in amino acid sequence from the ZmMADS1 gene reported in the literature. The 1-point difference in the amino acid sequence resides in the K domain, which is involved in mediating protein intermolecular interactions; the other 4 point differences are all located at the C-terminal C-domain, which mediates different MADS-box proteins to exert different effects.
At present, the application of the gene similar to maize 'early 15' has not been reported. The rice MADS-box gene (CN 00813062.0) has been reported in the existing domestic patent to have a function of regulating plant branching. MADS transcription factor families SILKY1 (CN 200880019049.4) and ZMM28 (CN 201980026679.2) in maize can increase grain yield. In addition, the ZmMADS15 can regulate and control the corn laying time and the corn scattering time under the condition of short sunshine. However, zmMADS15 did not affect the corn laying time and the meal time under long sun conditions (CN 115011628A).
Therefore, there is still a need to find genes which regulate plant growth and development, and have important application value especially for maize early maturing and dwarf direction breeding.
Summary of The Invention
The invention has important application value for early ripening of plants, especially corns, and dwarf direction breeding.
The inventor finds that the plant, especially the corn plant, can lead the flowering period and the maturity of the plant, especially the corn plant, to be advanced under the conditions of short sunlight and long sunlight by over-expressing the early 15 gene in the plant, especially the corn, and the plant height and the spike position to be reduced; by mutating the early 15 gene by a gene editing technology, plants with delayed flowering and maturity, especially maize plants, can be obtained.
Therefore, the invention aims to provide a maize early 15 gene, a coded protein thereof and application thereof in regulating plant growth and development, in particular to application of the gene in regulating maize early ripening and dwarf.
Thus, according to a first aspect, the present invention relates to the maize "early 15" gene.
The corn 'early 15' gene source of the invention is Zheng 58, and the Zea mays (B73 RefGen_v3) version is encoded as follows: GRMZM2G171365, zea mays (Zm-B73-REFERENCE-GRAMENE-4.0) version coded as Zm00001d048474, and Zea mays (Zm-B73-REFERENCE-NAM-5.0) version coded as Zm00001eb403750 (see FIG. 1).
Gene sequence information
The invention 'early 15' gene related sequence
GRMZM2G171365cDNA (Zheng 58) (SEQ ID NO: 1)
CGGCCATCACGGTGCGCCCTTTCCCTTCCTCCCCAGATCCCCGTCCCCGTTTTCCACTTTTGCCTCCGCCCCAATTCGGATAACAAACCCCTCCGCCTCGTCGCGTCTCCTCCCAGCCGAGCCGATCCGGTAGAGAGAGGGAGAGGGAGAGGGAGGGACTGAGGGAGGAGGAGCTGGGTTCCGGTCCCGGCCGCCCGGCCGGCTGCGCGATTCGATTGTAGCTCTCGTCCCCGGGCGGCGTCCAGGATGGTGCGGGGCAAGACGCAGATGAAGCGAATAGAGAACCCGACCAGCCGCCAGGTCACCTTCTCCAAGCGCCGCAACGGCCTGCTCAAGAAGGCGTTCGAGCTCTCCGTCCTCTGCGACGCCGAGGTCGCCCTCGTCGTCTTCTCCCCGCGCGGCAAGCTCTACGAATTCGCCAGCGGAAGTGCGCAGAAAACGATTGAACGTTATAGAACATACACAAAGGATAATGTCAGCAACAAGACAGTGCAGCAGGATATTGAGCGAGTAAAAGCTGATGCGGATGGCCTGTCAAAGAGACTTGAAGCACTTGAAGCTTACAAAAGGAAACTTTTGGGTGAGAGGTTGGAAGACTGCCCCATTGAAGAGCTGCACAGTTTGGAAGTCAAGCTTGAGAAGAGCCTGCATTGCATCAGGGGAAGAAAGACTGAGCTGCTGGAGGAGCAAGTCCGTAAGCTGAAGCAGAAGGAGATGAGTCTGCGCAAGAGCAACGAAGATTTGCGTGAAAAGTGCAAGAAGCAGCCGCCTGTGCCGATGGCTCCGCCGCCGCCTCGTGCGCCGGCAGTCGACACCGTGGAGGACGATCACCGGGAGCCGAAGGACGACGGAATGGACGTGGAGACGGAGCTGTACATAGGATTGCCCGGCAGAGACTACCGCTCAAGCAAAGACAAGGCTGCAGTGGCGGTCAGGTCAGGCTAGCAGCTAGCTCAGCCACGCACAGGCCCAATCAACGCAAGCTAGCTAGCTGAGAATAATCTTTTAGATCTCTGGTAGTGTGGAGATCGAGATGCAAGCCAAGCAATGTGATATCGCGTCGTGTGTTACCAAAAAAAAAAAAAAAAGTCAGTCAGGCCA
GRMZM2G171365CDS (Zheng 58) (SEQ ID NO: 3)
ATGGTGCGGGGCAAGACGCAGATGAAGCGAATAGAGAACCCGACCAGCCGCCAGGTCACCTTCTCCAAGCGCCGCAACGGCCTGCTCAAGAAGGCGTTCGAGCTCTCCGTCCTCTGCGACGCCGAGGTCGCCCTCGTCGTCTTCTCCCCGCGCGGCAAGCTCTACGAATTCGCCAGCGGAAGTGCGCAGAAAACGATTGAACGTTATAGAACATACACAAAGGATAATGTCAGCAACAAGACAGTGCAGCAGGATATTGAGCGAGTAAAAGCTGATGCGGATGGCCTGTCAAAGAGACTTGAAGCACTTGAAGCTTACAAAAGGAAACTTTTGGGTGAGAGGTTGGAAGACTGCCCCATTGAAGAGCTGCACAGTTTGGAAGTCAAGCTTGAGAAGAGCCTGCATTGCATCAGGGGAAGAAAGACTGAGCTGCTGGAGGAGCAAGTCCGTAAGCTGAAGCAGAAGGAGATGAGTCTGCGCAAGAGCAACGAAGATTTGCGTGAAAAGTGCAAGAAGCAGCCGCCTGTGCCGATGGCTCCGCCGCCGCCTCGTGCGCCGGCAGTCGACACCGTGGAGGACGATCACCGGGAGCCGAAGGACGACGGAATGGACGTGGAGACGGAGCTGTACATAGGATTGCCCGGCAGAGACTACCGCTCAAGCAAAGACAAGGCTGCAGTGGCGGTCAGGTCAGGCTAG
GRMZM2G171365 amino acid (Zheng 58) (SEQ ID NO: 2)
MVRGKTQMKRIENPTSRQVTFSKRRNGLLKKAFELSVLCDAEVALVVFSPRGKLYEFASGSAQKTIERYRTYTKDNVSNKTVQQDIERVKADADGLSKRLEALEAYKRKLLGERLEDCPIEELHSLEVKLEKSLHCIRGRKTELLEEQVRKLKQKEMSLRKSNEDLREKCKKQPPVPMAPPPPRAPAVDTVEDDHREPKDDGMDVETELYIGLPGRDYRSSKDKAAVAVRSG
1.3 Zheng 58 and B73 sequence comparison
The GRMZM2G171365 gene contained 1 long intron, 3 short introns in the B73 database; the gene has 4 transcripts (T01 is identical to T04), wherein T01 is longest and translates 232 amino acids. The CDS length obtained from Zheng 58 clone was most similar to the T01 CDS in the B73 database, and the GRMZM2G171365CDS (Zheng 58) sequence was 8-point different from the GRMZM2G 171365-T01 CDS (B73) sequence (see FIG. 2).
The number of translated amino acids of GRMZM2G171365CDS (Zheng 58) and GRMZM2G171365_T01 CDS (B73) are identical, but the amino acid sequence has 5 point differences: P119S, P180S, P181A, T190N, D G (fig. 3). The 1-point difference in the amino acid sequence resides in the K domain, which is involved in mediating protein intermolecular interactions; the other 4 point differences are all located at the C-terminal C-domain, which mediates different roles of different MADS-box proteins (see FIG. 3).
The present invention provides an isolated nucleic acid molecule, characterized in that it comprises a sequence selected from the group consisting of:
1) A nucleotide sequence shown in SEQ ID NO. 1;
2) A nucleotide sequence with at least 85%, 90%, 91%, 92%, 93%, 94%, 95%, 96%, 97%, 98%, 99% or 99.5% identity with the nucleotide sequence shown in SEQ ID NO. 1, wherein the encoded polypeptide has the function of regulating plant growth and development;
3) A nucleotide sequence which hybridizes under stringent conditions to the sequence shown in SEQ ID No. 1;
4) Expressing the nucleotide sequence of the same or functionally deleted or mutated protein by substituting and/or deleting and/or adding one or more nucleotides in the nucleotide sequence shown in SEQ ID NO. 1;
5) Different transcripts were produced from the nucleotide sequence shown in SEQ ID No. 1.
In another aspect, the invention also provides an isolated nucleic acid molecule, characterized in that it comprises a sequence selected from the group consisting of:
1) A nucleotide sequence encoding the amino acid sequence shown in SEQ ID NO. 2;
2) A nucleotide sequence encoding an amino acid sequence having at least 85%, 90%, 91%, 92%, 93%, 94%, 95%, 96%, 97%, 98%, 99% or 99.5% identity to the amino acid sequence shown in SEQ ID NO. 2, wherein the encoded polypeptide has the function of regulating plant growth;
3) A nucleotide sequence encoding an amino acid sequence obtained by substitution and/or deletion and/or addition of one or more amino acid residues in the amino acid sequence shown in SEQ ID NO. 2, and a polypeptide encoded thereby has a function of regulating plant growth and development.
In another aspect, the invention provides an isolated nucleic acid molecule characterized in that it comprises a sequence selected from the group consisting of:
1) A nucleotide sequence shown in SEQ ID NO. 3;
2) A nucleotide sequence having at least 85%, 90%, 91%, 92%, 93%, 94%, 95%, 96%, 97%, 98%, 99% or 99.5% identity with the nucleotide sequence shown in SEQ ID NO. 3, wherein the encoded polypeptide has the function of regulating plant growth and development;
3) A nucleotide sequence which hybridizes under stringent conditions to the sequence shown in SEQ ID No. 3;
4) Expressing the nucleotide sequence of the same or functionally deleted or mutated protein by substituting and/or deleting and/or adding one or more nucleotides in the nucleotide sequence shown in SEQ ID NO. 3;
5) Different transcripts were produced from the nucleotide sequence shown in SEQ ID NO. 3.
In another aspect, the invention provides an isolated polypeptide, characterized in that it is transcribed and/or expressed from a nucleic acid molecule as described in the above aspects.
In another aspect, the invention provides an isolated polypeptide comprising an amino acid sequence selected from the group consisting of seq id no:
1) An amino acid sequence shown in SEQ ID NO. 2;
2) An amino acid sequence having at least 85%, 90%, 91%, 92%, 93%, 94%, 95%, 96%, 97%, 98%, 99% or 99.5% identity to the amino acid sequence shown in SEQ ID NO. 2, said polypeptide having the function of regulating plant growth;
3) The polypeptide has the function of regulating plant growth and development by substituting and/or deleting and/or adding one or more amino acid residues in the amino acid sequence shown in SEQ ID NO. 2.
In another aspect, the invention provides a recombinant vector comprising a nucleic acid molecule as described in the above aspects.
In another aspect, the invention provides a host cell comprising a nucleic acid molecule as described in the above aspect, or comprising a polypeptide as described in the above aspect, or comprising a recombinant vector as described in the above aspect.
In another aspect, the invention provides a transgenic plant characterized by comprising a nucleic acid molecule as described in the above aspect, or comprising a recombinant vector as described in the above aspect.
In some embodiments, the transgenic plant is a monocot or dicot, preferably a crop plant.
In some specific embodiments, the transgenic plant is selected from one or more of maize (Zea mays), sorghum (Sorghum bicolor), sorghum vulgare, soybean (Glycine max), wheat (Triticum aestivum), rice (Oryza sativa), cotton (such as gossypium barbadense (Gossypium barbadense), canola (Brassica campestris), cabbage (Brassica oleracea), canola (Brassica napus), mustard (Brassica juncea), barley (Hordeum vulgare), rye (SECALE CEREALE), oat (AVENA SATIVA), millet (such as pearl millet (Pennisetum glaucum)), tomato (Lycopersicon esculentum), sunflower (Helianthus annuus), potato (Solanum tuberosum), peanut (Arachis hypogaea), sweet potato (Ipomoea batatus), cassava (Manihot esculenta), sugar beet (Beta vulgares), sugarcane (Saccharum spp), tobacco (Nicotiana tabacum) or arabidopsis (Arabidopsis thaliana), preferably arabidopsis thaliana and maize, more preferably maize.
In another aspect, the invention provides the use of an isolated nucleic acid molecule as described in the above aspect or an isolated polypeptide as described in the above aspect or a recombinant vector as described in the above aspect for regulating plant growth.
In another aspect, the invention provides the use of an isolated nucleic acid molecule as described in the above aspect or an isolated polypeptide as described in the above aspect or a recombinant vector as described in the above aspect for regulating early maturity and stumps in plants.
In some embodiments, the application comprises the steps of:
1) Introducing the nucleic acid molecule described in the above aspect or the recombinant vector described in the above aspect into a plant of interest to obtain an overexpressed transgenic plant; and
2) The plants are grown such that the over-expressed transgenic plants have early maturing and dwarf performance compared to control plants.
In another aspect, the invention provides the use of an isolated nucleic acid molecule as described in the above aspect or an isolated polypeptide as described in the above aspect or a recombinant vector as described in the above aspect for regulating late maturation of a plant.
In some embodiments, the application comprises the steps of:
1) Disruption of the "early 15" gene in plants or genes homologous to the "early 15" gene in other plants to obtain transgenic plants; and
2) The plants are grown such that the transgenic plants have late-maturing properties compared to control plants.
In some embodiments, the disruption is achieved by knocking out or knocking down the "early 15" gene.
In some embodiments, the disruption is achieved by a genome editing system of CRISPR/Cas, TALEN, ZFN or other gene editing system.
In another aspect, the invention provides the use of a nucleic acid molecule as described in the above aspect or a polypeptide as described in the above aspect or a recombinant vector as described in the above aspect for breeding plants with altered traits.
In some embodiments, the plant is a monocot or dicot, preferably a crop plant.
In some specific embodiments, the transgenic plant is selected from one or more of corn, sorghum, soybean, wheat, rice, cotton, canola, cabbage, canola, mustard, barley, rye, oat, millet, tomato, sunflower, potato, peanut, sweet potato, cassava, sugar beet, sugarcane, tobacco, or arabidopsis; preferably Arabidopsis thaliana and corn; more preferably corn.
In another aspect, the invention provides a method of regulating the growth and development of a plant comprising:
1) Introducing the isolated nucleic acid molecule of the above aspect, or the recombinant vector of the above aspect, into a plant of interest to obtain a transgenic plant; and
2) Cultivating the plant, wherein the transgenic plant has the properties of early maturing and dwarfing compared to a control plant.
In another aspect, the invention provides a method of regulating the growth and development of a plant comprising:
1) Disruption of the "early 15" gene in plants or genes homologous to the "early 15" gene in other plants to obtain transgenic plants; and
2) Cultivating the plant, wherein the transgenic plant has late-maturing performance compared to a control plant.
In another aspect, the present invention provides a method of producing a transgenic plant comprising the isolated nucleic acid molecule according to the above aspect introduced, or the recombinant vector according to the above aspect, or the isolated polypeptide according to the above aspect expressed recombinantly, characterized in that the method comprises the steps of:
1) Obtaining seeds of said transgenic plant;
2) Planting the seeds to obtain the transgenic plant with stable inheritable characters.
In another aspect, the present invention provides a method of producing a transgenic plant comprising a gene that disrupts the "early 15" gene in the plant or is homologous to the "early 15" gene in other plants, characterized in that the method comprises the steps of:
1) Obtaining seeds of said transgenic plant;
2) Planting the seeds to obtain the transgenic plant with stable inheritable characters.
In some specific embodiments, the transgenic plant is selected from one or more of corn, sorghum, soybean, wheat, rice, cotton, canola, cabbage, canola, mustard, barley, rye, oat, millet, tomato, sunflower, potato, peanut, sweet potato, cassava, sugar beet, sugarcane, tobacco, or arabidopsis; preferably Arabidopsis thaliana and corn; more preferably corn.
Drawings
FIG. 1 shows a summary of different versions of the "early 15" gene.
FIG. 2 shows CDS sequence differences for the "early 15" gene in Zheng 58 and B73.
FIG. 3 shows the amino acid sequence differences of the "early 15" gene in Zheng 58 and B73. MADS-box domain (3-75), K-box domain (83-169), C domain (170-231).
FIG. 4 shows pBCXUN vector maps.
FIG. 5 shows recombinant expression vector pBXCUN- "early 15".
FIG. 6 shows the relative expression of the "early 15" gene in leaves of control plants and transgenic plants of the invention.
FIG. 7 shows the structure of gene editing vector pXUE C.
FIG. 8 shows a comparison of the number of days to powder of control plants and transgenic inbred plants overexpressing the invention for each year. By Dunnett's test analysis, p.ltoreq.0.05; * P is less than or equal to 0.01.
FIG. 9 shows a comparison of the days of silking of control plants of each year and transgenic inbred plants overexpressing the invention. By Dunnett's test analysis, p.ltoreq.0.05; * P is less than or equal to 0.01.
FIG. 10 shows a comparison of maturity days for control plants and plants of the over-expressed transgenic inbred of the invention. By Dunnett's test analysis, p.ltoreq.0.05; * P is less than or equal to 0.01.
FIG. 11 shows a comparison of the number of days to powder of control plants and plants of the over-expressed transgenic hybrids of the present invention for each year. By Dunnett's test analysis, p.ltoreq.0.05; * P is less than or equal to 0.01.
FIG. 12 shows a comparison of the number of days of laying for each year of control plants and plants of the over-expressed transgenic hybrids of the invention. By Dunnett's test analysis, p.ltoreq.0.05; * P is less than or equal to 0.01.
FIG. 13 shows a comparison of maturity days for control plants and plants of the over-expressed transgenic hybrids of the present invention. By Dunnett's test analysis, p.ltoreq.0.05; * P is less than or equal to 0.01.
FIG. 14 shows a comparison photograph of milk lines of a control plant and an over-expressed transgenic hybrid spike of the invention (panel A is a control plant, panel B is a transgenic hybrid plant of the invention).
FIG. 15 shows photographs of flowering phase versus plant height of control plants and transgenic inbred plants of the invention (panels A and B, left control plants, right transgenic inbred plants of the invention).
FIG. 16 shows a photograph of the flowering phase versus plant height of control plants and of the over-expressed transgenic hybrid plants of the invention (panels A and B, left control plants, right transgenic hybrid plants of the invention).
FIG. 17 shows a comparison of the days to powder dispersion for control plants and gene-edited plants of the invention. By Dunnett's test analysis, p.ltoreq.0.05; * P is less than or equal to 0.01.
FIG. 18 shows a comparison of the number of days of laying for control plants and gene-edited plants of the invention. By Dunnett's test analysis, p.ltoreq.0.05; * P is less than or equal to 0.01.
Figure 19 shows a comparison of plant heights for control plants and over-expressed transgenic inbred plants of the invention for each year. By Dunnett's test analysis, p.ltoreq.0.05; * P is less than or equal to 0.01.
FIG. 20 shows a comparison of ear positions of control plants and transgenic inbred plants overexpressing the invention for each year. By Dunnett's test analysis, p.ltoreq.0.05; * P is less than or equal to 0.01.
FIG. 21 shows a comparison of plant heights for control plants and over-expressed transgenic hybrid plants of the invention for each year. By Dunnett's test analysis, p.ltoreq.0.05; * P is less than or equal to 0.01.
FIG. 22 shows a comparison of ear positions of control plants and over-expressed transgenic hybrid plants of the invention for each year. By Dunnett's test analysis, p.ltoreq.0.05; * P is less than or equal to 0.01.
Detailed Description
The following definitions and illustrations are provided to better define the invention and to guide those of ordinary skill in the art in practicing the invention. Unless defined otherwise, all technical and scientific terms used herein have the same meaning as commonly understood by one of ordinary skill in the art to which this invention belongs. Unless specifically stated otherwise, the techniques employed and contemplated herein are standard methods well known to those skilled in the art to which the present invention pertains. The materials, methods, and examples are illustrative only and not intended to limit the scope of the present invention in any way.
As used herein, "plant" includes whole plants, transgenic plants, meristems, parts of plants, plant cells, and progeny thereof. Parts of a plant include, but are not limited to, leaves, stems, tubers, roots, flowers (including, for example, bracts, sepals, petals, stamens, carpels, anthers, ovules, etc.), fruits, embryos, endosperm, seeds, pollen, meristematic tissue, callus, protoplasts, microspores, and the like.
As described herein, useful plant species generally encompass higher plant species suitable for transgenic technology, including angiosperms (monocotyledonous and dicotyledonous plants), gymnosperms, ferns, scouring rush, gymnosperms, pinus, bryophytes, and multicellular algae.
In some embodiments, the parts or plant cells of the plants of the invention are regenerable. In other embodiments, the parts or plant cells of the plants of the invention are non-regenerable.
In a specific embodiment, the plants suitable for the present invention are selected from the following: corn, sorghum, soybean, wheat, rice, cotton, canola, cabbage, canola, mustard, barley, rye, oat, millet, tomato, sunflower, potato, peanut, sweet potato, cassava, sugar beet, sugarcane, tobacco, arabidopsis, and the like. Preferably, the plant suitable for use in the present invention is maize or rice.
As used herein, the term "transgene" refers to a polynucleotide molecule that is artificially introduced into the genome of a host cell. Such transgenes may be heterologous to the host cell. The term "transgenic plant" refers to a plant comprising the heterologous polynucleotide described above, and transgenic plants include plants regenerated from initially transformed plant cells and progeny transgenic plants from subsequent generation or crossing of the transgenic plant.
Any method known to those skilled in the art can be used to obtain transgenic plants, for example by electroporation or microinjection of plant cell protoplasts into heterologous nucleic acid sequences; or introducing the heterologous nucleic acid sequence directly into the plant tissue cells by DNA microprojectile bombardment (DNA PARTICLE template); or introducing the heterologous nucleic acid sequence into a plant cell using an Agrobacterium tumefaciens (Agrobacterium tumefaciens) host cell.
As used herein, "control plants" refers to plants that do not contain recombinant DNA that confers enhanced traits. Control plants are used to identify and select transgenic plants with enhanced traits. Suitable control plants may be non-transgenic plants of the parental line used to generate the transgenic plants, e.g., wild type plants (WTs). Suitable control plants may also be transgenic plants containing recombinant DNA conferring other traits, e.g., transgenic plants with enhanced herbicide tolerance.
As used herein, "trait" refers to a physiological, morphological, biochemical or physical characteristic of a plant or a particular plant material or cell. In some cases, the characteristic is visible to the human eye, such as seed or plant size, or may be measured by biochemical techniques (e.g., detecting protein, starch, certain metabolites, or oil content of seeds or leaves) or by observing metabolic or physiological processes (e.g., by measuring tolerance to water deprivation or specific salt or sugar concentrations) or by measuring the expression level of one or more genes (e.g., using Northern analysis, RT-PCR, microarray gene expression assays, or reporter gene expression systems) or by agricultural observations (e.g., tolerance to hyperosmotic stress and yield). Any technique can be used to measure the amount, comparison level or difference of any selected chemical compound or macromolecule in the transgenic plant.
As used herein, "gene" or "gene sequence" refers to the partial or complete coding sequence of a gene, its complement, and its 5 'and/or 3' untranslated regions. Genes are also genetic functional units and are physically specific segments or sequences of nucleotides of molecules along the DNA (or RNA, in the case of RNA viruses) that are involved in the production of polypeptide chains. The latter may undergo subsequent processing, such as chemical modification or folding, to obtain a functional protein or polypeptide. By way of example, a transcriptional regulatory gene encodes a transcriptional regulatory polypeptide, which may be functional or require processing to act as a trigger for transcription.
As used herein, the term "nucleic acid" refers to any polymer comprising deoxyribonucleotides or ribonucleotides, including but not limited to modified or unmodified DNA, RNA, the length of which is not subject to any particular limitation. For nucleic acids used to construct the recombinant construct, DNA is preferred, which is more stable and easier to manipulate than RNA.
The term "DNA" refers to a double-stranded DNA molecule of genomic or synthetic origin, i.e., a polymer of deoxyribonucleotide bases or a nucleotide molecule, read from the 5 'end (upstream) to the 3' end (downstream). The term "nucleotide sequence" refers to the sequence of nucleotides of a DNA or RNA molecule that is typically displayed from the 5 '(upstream) end to the 3' (downstream) end.
Methods known to those of skill in the art may be used to isolate and describe the DNA molecules or fragments thereof. For example, PCR (polymerase chain reaction) techniques can be used to amplify specific starting DNA molecules and/or to generate variants of the original molecule. The DNA molecule or fragment thereof may also be obtained by other techniques, such as direct synthesis of the fragment by chemical means (e.g. an automated oligonucleotide synthesizer).
The term "transcript" refers to a product of transcription of a DNA nucleotide sequence catalyzed by an RNA polymerase. When the RNA transcript is a perfect complementary copy of the DNA sequence, it is referred to as a primary transcript, or it may be RNA obtained by post-transcriptional processing of a primary transcript, referred to as mature RNA.
The term "isolated" means that the molecule is at least partially separated from other molecules to which it is normally attached in its native or natural state.
In some embodiments, the term "isolated nucleic acid molecule" refers to a nucleic acid molecule that is at least partially separated from nucleic acids that normally flank the nucleic acid molecule in an autologous or natural state. Thus, nucleic acid molecules fused to regulatory or coding sequences to which they are not normally linked are considered isolated herein, as a result of recombinant techniques. Such molecules are considered isolated even when integrated into the chromosome of a host cell or present in a nucleic acid solution with other nucleic acid molecules.
As used herein, a "polypeptide" comprises a plurality of consecutive polymeric amino acid residues, e.g., at least about 15 consecutive polymeric amino acid residues. Typically, a polypeptide comprises a series of polymeric amino acid residues that are transcriptional modulators or domains or portions or fragments thereof. Furthermore, the polypeptide may comprise: (i) a localization domain; (ii) an activation domain; (iii) an inhibitory domain; (iv) an oligomerization domain; (v) a protein-protein interaction domain; (vi) a DNA binding domain; or other portion. The polypeptide optionally comprises modified amino acid residues, naturally occurring amino acid residues not encoded by a codon, non-naturally occurring amino acid residues.
As used herein, "protein" refers to a series of amino acids, oligopeptides, peptides, polypeptides, or portions thereof, whether naturally occurring or synthetic.
The term "isolated polypeptide" refers to a polypeptide, whether naturally occurring or recombinant, that is present in a cell (or extracellular) in a greater amount than the polypeptide in its natural state in a wild-type cell, e.g., in an amount of greater than about 5% or greater than about 10% or greater than about 20% or greater than about 50% or greater, alternatively expressed as: the content is 105%,110%,120%,150% or more relative to the wild-type polypeptide homogenized at 100%. This is not the result of the natural response of wild type plants. In addition, the isolated polypeptides are separated from other normally associated cellular components, for example, using various protein purification methods.
As used herein, "percent identity", "% identity" or "percent identity" is a comparison between amino acid sequences or nucleotide sequences, as determined by comparing two sequences optimally aligned over a window of comparison (e.g., for optimal alignment with another nucleotide sequence or amino acid sequence, gaps can be introduced in the first nucleotide sequence or amino acid sequence). Those skilled in the art know how to calculate the percent identity between two sequences, for example, by various software such as Clustal, bestfit, blast, fasta. Percent identity is determined by: the number of positions of the same nucleotide or amino acid in both sequences is calculated, divided by the full length of the reference sequence (excluding gaps introduced into the reference sequence by the alignment process), and multiplied by 100%. The reference sequence may be as shown in SEQ ID NO.1, SEQ ID NO. 3 or SEQ ID NO.5, or SEQ ID NO. 2, SEQ ID NO. 4 or SEQ ID NO. 6. One of the other sequences may have one or more amino acid/nucleotide insertions, substitutions and deletions relative to the reference sequence.
In some embodiments, the nucleotide sequence of the present invention has at least 85%, 86%, 87%, 88%, 89%, 90%, 91%, 92%, 93%, 94%, 95%, 96%, 97%, 98%, 99% or 100% identity to the nucleotide sequence set forth in SEQ ID NO. 1.
In some embodiments, the polypeptide sequences of the invention have at least 85%, 86%, 87%, 88%, 89%, 90%, 91%, 92%, 93%, 94%, 95%, 96%, 97%, 98%, 99% or 100% identity to the amino acid sequence set forth in SEQ ID NO. 2.
As used herein, the term "stringent conditions" or "stringent hybridization conditions" includes conditions under which a probe hybridizes to a target sequence with a higher degree of detectability than other sequences (e.g., at least twice as high as background). Stringent conditions will be different depending on the sequence and circumstances. By adjusting the stringency of hybridization and/or wash adjustments, target sequences up to 100% complementary to the probe can be detected. Alternatively, the stringency can be adjusted so that some mismatches exist in the sequences, thereby detecting target sequences of lower identity. Hybridization specificity depends on the wash step after hybridization, the key factors being the salt concentration and temperature in the wash solution. Both the temperature and salt concentration may be varied, or the temperature or salt concentration may remain unchanged while another variable is changed, as desired. Suitable stringent conditions for promoting DNA hybridization are known to those skilled in the art. Examples of low stringency conditions are: hybridization was performed at 37℃in a buffer containing 30-35% formamide, 1M NaCl, 1% SDS, and washing with 1-2 XSSC (sodium chloride/sodium citrate) at 50℃to 55 ℃. Examples of moderately stringent conditions are: hybridization was performed at 37℃in a buffer containing 40-45% formamide, 1M NaCl, 1% SDS, and washed with 0.5-1 XSSC at 55℃to 60 ℃. Examples of highly stringent conditions are: hybridization was performed at 37℃in a buffer containing 50% formamide, 1M NaCl, 1% SDS, and washed with 0.1 XSSC at 60℃to 65 ℃. For a detailed description of nucleic acid hybridization see Haymes et al, nucleic Acid Hybridization, APRACTICAL APPROACH, IRL Press, washington, DC (1985); and Sambrook et al Current Protocols in Molecular Biology, john Wiley & Sons, N.Y. (1989), 6.3.1-6.3.6.
As used herein, "insertions," "deletions," or "substitutions" of one or more nucleotides or amino acids, where the insertions, deletions, and/or substitutions do not impair the function of the original sequence (e.g., in this context, refer to functions that still preserve drought resistance and/or increase crop yield under drought conditions). Those skilled in the art are aware of methods for accomplishing one or more nucleotide/amino acid insertions, deletions, and/or substitutions in the original sequence while preserving the biological function of the original sequence. Such insertions, deletions and/or substitutions are chosen to be made in non-conserved regions; or modifying a nucleotide by "silent variation" without altering the polypeptide encoded by the nucleotide based on the degeneracy of the genetic code; alternatively, one amino acid in a protein is replaced by another amino acid of similar nature by "conservative substitutions" without affecting the biological function of the protein. Conservative substitutions may occur within the following groups: 1) Acidic (negatively charged) amino acids such as aspartic acid and glutamic acid; 2) Basic (positively charged) amino acids such as arginine, histidine and lysine; 3) Neutral polar amino acids such as glycine, serine, threonine, cysteine, tyrosine, asparagine, and glutamine; and 4) neutral nonpolar (hydrophobic) amino acids such as alanine, leucine, isoleucine, valine, proline, phenylalanine, tryptophan and methionine. Conservative substitutions for amino acids within a native protein or polypeptide may be selected from other members of the group to which the naturally occurring amino acid belongs. For example, the group of amino acids having aliphatic side chains is glycine, alanine, valine, leucine and isoleucine; amino acid groups having aliphatic-hydroxyl side chains are serine and threonine; amino acid groups having amide-containing side chains are asparagine and glutamine; amino acid groups having aromatic side chains are phenylalanine, tyrosine and tryptophan; amino acid groups with basic side chains are lysine, arginine and histidine; and the group of amino acids having sulfur-containing side chains are cysteine and methionine. The natural conserved amino acid substitution groups are: valine-leucine, valine-isoleucine, phenylalanine-tyrosine, lysine-arginine, alanine valine, aspartic acid-glutamic acid and asparagine-glutamine.
As used herein, the term "recombinant" refers to DNA and/or protein and/or organism forms that are not normally found in nature and are thus produced by human intervention. Such human intervention may result in recombinant DNA molecules and/or recombinant plants.
In some embodiments, the recombinant vector further comprises a promoter, terminator, regulatory sequence, selectable marker, and/or any other sequence necessary for expression thereof in a host cell operably linked to the nucleotide sequence. In some specific embodiments, the recombinant vector is a plasmid.
As used herein, the term "promoter" generally refers to a DNA molecule that is involved in the recognition and binding of RNA polymerase II and other proteins (trans-acting transcription factors) to initiate transcription.
In some embodiments, the promoter may be initially isolated from the 5 'untranslated region (5' utr) of the genomic copy of the gene; alternatively, the promoter may be a synthetically produced or manipulated DNA molecule. In some embodiments, the promoter may also be chimeric, i.e., a promoter produced by fusion of two or more heterologous DNA molecules. Plant promoters include promoter DNA obtained from plants, plant viruses, fungi, and bacteria (e.g., agrobacterium). In some embodiments, the promoter is a developmentally regulated, organelle specific, tissue specific, inducible, constitutive, or cell specific promoter.
As used herein, "operably linked" is used interchangeably with "operably linked" to refer to a functional linkage between a first sequence (e.g., a promoter) and a second sequence (e.g., a gene of interest), wherein the promoter sequence initiates and mediates transcription of the second sequence. Typically, the two sequences operably linked are contiguous. Those skilled in the art know how to select promoters, terminators and other sequences necessary for expression of a gene in a host cell.
In some specific embodiments, expression of a gene is controlled by a so-called "strong" promoter (i.e., a promoter with high transcriptional potential such that the gene is strongly expressed).
As used herein, "host cell" refers to a cell that contains a recombinant vector and supports replication and/or expression of the expression vector. The host cell may be a prokaryotic cell (e.g., an E.coli cell, an Agrobacterium tumefaciens cell) or a eukaryotic cell (e.g., a yeast, insect, plant or animal cell).
In some embodiments, the host cell is preferably a monocot or dicot cell, including, but not limited to, cells from maize, sorghum, soybean, wheat, rice, cotton, canola, cabbage, canola, mustard, barley, rye, oat, millet, tomato, sunflower, potato, peanut, sweet potato, cassava, sugar beet, sugarcane, tobacco, arabidopsis. Preferably, the host cell is a maize cell or a rice cell; more preferably, the host cell is a maize cell.
As used herein, "introducing" a nucleic acid molecule or expression vector into a plant or plant cell refers to transfecting, transforming, transducing or incorporating the nucleic acid molecule or recombinant expression vector into a host cell such that the nucleic acid molecule is capable of autonomous replication or expression in the host cell.
In some embodiments, the introduced nucleic acid molecule is integrated into host cell genomic DNA (e.g., chromosomal, plasmid, plastid, or mitochondrial DNA), and expression of the nucleotide sequence is under the control of a regulatory promoter region. In other embodiments, the introduced nucleic acid molecule is not integrated into the cell genome.
The CRISPR/Cas gene editing systems described herein include all components required for, for example, cas9 or modified Cas9 enzymes, guide RNAs, and/or homology-directed repair templates, and the like; comprising (a) a CRISPR/Cas system nucleotide sequence or a nucleotide sequence encoding a CRISPR/Cas system nucleotide sequence and/or (b) a nucleotide sequence encoding a CRISPR/Cas enzyme, which sequences may be comprised in one or more recombinant viral vectors. Wherein the nucleotide sequence of (a) may be located on the same or a different recombinant viral vector as the nucleotide sequence of (b).
In some embodiments, the viral vector may be a retroviral vector, optionally a lentiviral vector, a baculovirus vector, a herpes simplex viral vector, an adenovirus vector, an adeno-associated virus (AAV) vector (e.g., AAV8 vector), or a poxvirus (e.g., vaccinia virus).
In some embodiments, (a) the CRISPR/Cas system nucleotide sequence or the nucleotide sequence encoding the CRISPR/Cas system nucleotide sequence and/or (b) the nucleotide sequence encoding the CRISPR/Cas enzyme may be delivered to a cell of an organism by a liposome, nanoparticle, exosome, microvesicle, or gene gun.
In some specific embodiments, the preferred CRISPR/Cas enzyme is a type II CRISPR/Cas enzyme, preferably a type II Cas9 enzyme or a biologically active fragment or derivative thereof.
The corn 'early 15' gene sequence related to the application is Zheng 58, and the Zea mays (B73 RefGen_v3) version codes as follows: GRMZM2G171365, zea mays (Zm-B73-REFERENCE-GRAMENE-4.0) version coded as Zm00001d048474, and Zea mays (Zm-B73-REFERENCE-NAM-5.0) version coded as Zm00001eb403750. Because the same segment of DNA sequence of corn can produce different transcripts and translate different proteins, the different transcripts produced by the segment of sequence and the translated different proteins are all within the protection scope of the application.
The invention uses the gene editing method to knock out the early 15 gene of corn, and can obtain late maturing corn plants; and the maize 'early 15' gene is overexpressed in maize, so that maize plants with early maturing and short stalks can be obtained. Therefore, the invention has important theoretical guiding significance and production application value for cultivating corns with early flowering and mature periods and reduced plant height and spike position.
The invention has the following technical effects:
In the embodiment of the invention, the maize plant with early maturing and short stalk can be obtained by over-expressing the maize 'early 15' gene in maize. Compared with the traditional breeding mode, the flowering phase and the mature phase of the transgenic corn with the 'early 15' gene over-expression are both obviously and stably advanced, and the plant height and the ear position are both obviously and stably reduced. Therefore, the invention provides gene resources for cultivating and improving corn, and provides theoretical basis for elucidating important roles of early 15 gene in plant growth and development, especially early maturing and short stalk. In conclusion, the invention widens the sources of the excellent alleles available in plant breeding and provides a new idea for obtaining the excellent alleles; greatly shortens the selection process of the excellent allele and provides possibility for the application of the excellent allele.
Detailed Description
The maize acceptor material inbred used in the following examples was ND101; the agrobacterium strain is EHA105.
Example 1 construction of over-expression vector design and creation of transgenic Material
1.1 Carrier frameworks
PBCXUN: the HYG gene is modified based on a vector pCXUN (NCBI GenBank: FJ 905215) and replaced by Bar through XhoI locus; the Bar gene is from pCAMBIA3301, pCXUN, the promoter for promoting the expression of target gene is corn Ubiquitin-1, and the terminator is T-nos.
The vector map is shown in FIG. 4.
1.2 Construction of the "early 15" Gene overexpression vector
First, RNA was extracted from the V4 leaf of Zheng 58 of maize variety using a magnetic bead method plant total RNA extraction kit (Peking Baitaike Biotechnology Co., ltd., cat. No. AU 3402) according to the manufacturer's instructions, and then the RNA was reverse transcribed into cDNA using High-CAPACITY CDNA REVERSE Transcription Kit (Thermo Scientific Co., ltd., cat. No. 4368814), and a whole genome cDNA library was constructed. Then, the cDNA library was sequenced, a plasmid containing the complete CDS sequence of the "early 15" gene was selected by bioinformatics method with reference to published B73 sequence and gene annotation, and the CDS sequence of the "early 15" gene was obtained by restriction enzyme digestion with the restriction enzyme Quick cut SfiI (TaKaRa, cat# 1637) (GRMZM 2G171365cDNA (Zheng 58)). The purified "early 15" CDS sequence was ligated with pBCXUN vector (NCBI GenBank: FJ905215, see, e.g., plant Physiol.150 (3), 1111-1121 (2009)) to give recombinant expression vector pBCXUN- "early 15" (see FIG. 5). The recombinant expression vector is used to transform colibacillus, positive clone is screened, and the complete early 15 gene is confirmed by sequencing.
1.3 Preparation of transgenic maize overexpressing the "early 15" Gene
Recombinant expression vector pBXCUN- "early 15" is introduced into agrobacterium EHA105 strain to obtain recombinant strain. Then, the recombinant bacteria are led into maize inbred line ND101 by an agrobacterium-mediated method to obtain a T 0 generation transgenic plant.
And taking seedling leaves of T 0 generation transgenic plants, and extracting genome DNA. PCR amplification was performed using the genomic DNA as a template, and primer Ubip-F (5 'end of Ubi1P promoter against recombinant expression vector pBXCUN- "early 15") and primer Nos-R (3' end of Nos terminator against recombinant expression vector pBXCUN- "early 15"). Genomic DNA from maize inbred ND101 seedling leaves served as negative control, and plasmid of recombinant expression vector pBXCUN- "early 15" served as positive control.
Ubip-F:5’-TTTTAGCCCTGCCTTCATACGC-3’(SEQ ID NO:4);
Nos-R:5’-AGACCGGCAACAGGATTCAATC-3’(SEQ ID NO:5)。
The PCR amplification products were detected by agarose gel electrophoresis. The result shows that the transgenic plant and the plasmid can amplify a single band with the size of 1291bp, and the parent ND101 does not amplify a corresponding band, which indicates that the early 15 gene is successfully transferred into the transgenic plant.
Selfing the identified T 0 generation transgenic plant to obtain a T 1 generation transgenic plant offspring; selfing the progeny of the transgenic plant of the generation T 1 to obtain the progeny of the transgenic plant of the generation T 2; selfing the progeny of the transgenic plant of the generation T 2 to obtain the progeny of the transgenic plant of the generation T 3; the positive transgenic plants are identified in each generation by adopting the PCR amplification method, and then selfing is carried out. 3 representative T 3 -generation homozygous transgenic lines (i.e., early 15-1, early 15-2, early 15-3) were selected for subsequent functional analysis experiments.
1.4 Detection of expression level of early 15 Gene
This example uses 3 representative T3 generation homozygous transgenic lines (i.e., early 15-1, early 15-2, early 15-3) and maize inbred ND101 (WT) as test plants.
First, RNA of V4 leaf of the plant to be tested was extracted using a magnetic bead method plant total RNA extraction kit (Peking Baitaike Biotechnology Co., ltd., cat. No. AU 3402) according to the manufacturer's instructions, and then the RNA was reverse transcribed into cDNA using High-CAPACITY CDNA REVERSE Transcription Kit (Thermo Scientific Co., ltd., cat. No. 4368814).
Then, real-time fluorescent quantitative PCR amplification was performed using SYBR Premix Ex TaqTM II (TLI RNASEH Plus) kit (Takara Co., ltd., cat. No. RR 820A) and specific primers "early 15" -Q-F (5'-CTCCGCCGCCGCCTCGTG-3') (SEQ ID NO: 6) and "early 15" -Q-R (5'-CGTCCATTCCGTCGTCCTTC-3') (SEQ ID NO: 7) using cDNA as a template to detect the expression level of the "early 15" gene. The cDNA of maize inbred ND101 (WT) was used as a control. The maize action gene is used as an internal reference gene, and the detection primers are as follows: zmActin-rF:5'-GAGCTCCGTGTTTCGCCTGA-3' (SEQ ID NO: 8) and ZmActin-rR:5'-CAGTTGTTCGCCCACTAGCG-3' (SEQ ID NO: 9). The reaction procedure for fluorescent quantitative PCR amplification is shown in Table 1 below.
TABLE 1 reaction procedure for fluorescent quantitative PCR amplification
The results of the fluorescent quantitative PCR are shown in FIG. 6. As can be seen from FIG. 6, the expression level of "early 15" in transgenic lines early 15-1, early 15-2 and early 15-3 is significantly higher than that of the maize inbred line ND101 (WT) of the control plant. These results indicate that the "early 15" gene was successfully overexpressed in the T 3 generation homozygous transgenic lines early 15-1, early 15-2, and early 15-3.
EXAMPLE 2 creation of Gene editing vector and Gene editing Material
2.1 Gene editing vector backbone
The vector pBUE C used in this example was modified based on pBUE to construct an existing final vector pBUE C by replacing the resistance gene SpR with the gene ccdB, which is a lethal gene of E.coli F-plasmid negative strain, at BsaI site. After the vector is transferred into DH5 alpha, negative bacteria cannot grow, and the positive rate can be obviously improved to more than 90%. pBUE A related study result has been published (Xing et al BMC Plant biol.2014nov 29;14 (1): 327.) by professor of the functional genome of crops of Chinese university of agriculture in cooperation with molecular breeding research center, professor laboratory design of biological institute Chen Jijun.
The structure of gene editing vector pXUE C is shown in FIG. 7.
2.2 Design of early 15 Gene target and construction of Gene editing vector
The single-target gene knockout vector is designed and constructed 15M earlier, and a specific single-target sequence GGTGACCTGGCGGCTGGTC is constructed to a vector pBUE C. And (3) introducing the recombinant expression vector into an agrobacterium EHA105 strain to obtain recombinant bacteria. Then, the recombinant bacteria are led into maize inbred line ND101 by an agrobacterium-mediated method to obtain a T 0 generation transgenic plant.
2.2.1 Target design the website http:// crispor.tefor.net/search candidate targets were designed using the gene editing vector, and then screening was performed on candidate targets. Because the target design website is based on the inbred line which has completed sequencing, and is different from the transgenic receptor material, in order to ensure the gene editing efficiency, the target verification of the transgenic receptor material is required. The wild DNA of the maize inbred line of the receptor material is taken as a template, a specific primer is designed by referring to the DNA sequence of the target gene, sequencing verification is completed on a target sequence section covered by the receptor material, and the target sequence is completely consistent with the receptor material.
2.2.2 Target verification
The acceptor maize inbred line ND101 wild type DNA is used as a template, 30 mu l system PCR amplification is carried out by KOD enzyme, the primer is 15M- (-172) F & 15M-229R, and the PCR system and the Touch Down PCR are as follows. And 5. Mu.l of PCR product is taken for agarose gel electrophoresis detection, the fragment size of the PCR product is correct and specific, the rest products are directly sent and detected, the sequencing primer is 15M- (-172) F earlier, and whether the target sequence is completely matched with the receptor material is verified according to the sequencing result. And if the carrier is completely matched, carrying out the next carrier design construction.
Target verification primer:
Early 15M- (-172) F:5'-CCCCAATTCGGATAACAAACC-3' (SEQ ID NO: 10)
Early 15M-229R:5'-CTCGAACTCGAAGGGAAGACG-3' (SEQ ID NO: 11)
PCR amplification system:
PCR amplification procedure:
PCR amplified sequence (SEQ ID NO: 12):
2.2.3 vector construction
After confirming the target sequence, synthesizing a primer to construct a single target carrier: directly annealing the oligonucleotide chain containing the target sequence by using a PCR instrument and then connecting the oligonucleotide chain to the digested gene editing vector pBUE C; the principle and the construction method refer to articles published by a teacher of China agricultural university Chen Jijun. (Xing et al BMC Plant biol.2014Nov 29;14 (1): 327.).
The single target carrier construction primers were as follows:
CAU0574-BsF:5’-GGCGGGTGACCTGGCGGCTGGTC-3’(SEQ ID NO:13)
CAU0574-BsR:5’-AAACGACCAGCCGCCAGGTCACC-3’(SEQ ID NO:14)
The recombinant expression vector is used for transforming escherichia coli, positive clones are screened, plasmids are extracted and then sent to a sequencing company for sequencing, sequencing results are compared with target targets for analysis, the fact that the vector contains complete target sequences with PAM at the 3' end is ensured, the fact that the correct target sequences are introduced into pBUE C is indicated, and cloning construction is completed.
2.3 Creation of "early 15" Gene editing Material in ND101
The recombinant gene editing vector is introduced into an agrobacterium EHA105 strain at 15M to obtain recombinant bacteria. Then, the recombinant bacteria are led into a maize inbred line ND101 through an agrobacterium-mediated method, and T 0 generation transgenic seedlings are obtained by screening aiming at Bar resistance, thus obtaining T 0 generation transgenic plants.
And after genetic transformation and emergence of seedlings, taking seedling leaves of the T 0 -generation transgenic plants, and extracting genome DNA. Detecting the copy number of the resistance gene Bar by taking the genome DNA as a template, and screening to obtain a transgenic positive plant; and then selecting target spot verification primer early 15M- (-172) F & early 15M-229R to carry out gene editing detection on the target gene sequence, and carrying out PCR amplification. The PCR product is directly sent to a company for sequencing, the sequencing primer is 15M- (-172) F, the mutation type after gene editing is further analyzed, and mutant strains are screened.
Bar gene copy number and gene editing type are detected for their progeny T 1 generation plants, single plant phenotype screening is performed at T 1, and strains with phenotypes (early 15M-1, early 15M-2 and early 15M-3) are selected for field testing at T 2.
Example 3 flowering phase analysis of the over-expressed transgenic maize and Gene editing Material of the invention
3.1 Analysis of the growth period of overexpressed transgenic maize
The materials used in the test of the overexpression transgenic maize inbred line are pBCXUN- "early 15" lines early 15-1, early 15-2 and early 15-3, and ND101 is used as a control plant. The test material used in the over-expression transgenic corn hybrid test is that pBCXUN- "early 15" strain 3T3 generation homozygous transgenic strains are used as male parent and hybridized with T13 to obtain 3 transgenic homozygous strains F1 (namely F1-early 15-1, F1-early 15-2 and F1-early 15-3), and F1-ND101 obtained by hybridization of ND101 and T13 is used as control plant. Many years of multi-point experiments were performed on both inbred lines and hybrids. Early 15-1, early 15-2, early 15-3 and WT (ND 101) were planted in 2015 at 1 test point (long sunlight condition: princess, 2 replicates per point), 2020 at 2 test points (long sunlight condition: princess, short sunlight condition: unsealed summer sowing, 3 replicates per point), 2021 at 2 test points (long sunlight condition: princess, short sunlight condition: unsealed summer sowing, 3 replicates per point), 2022 at 1 test point (long sunlight condition: princess, 3 replicates per point). F1-early 15-1, F1-early 15-2, F1-early 15-3 and WT (F1-ND 101) were planted in 8 points (long sunshine condition: princess, baotou, zhuozhou, anyang spring sowing, yinchuan; short sunshine condition: anyang summer sowing, unsealed summer sowing, 2 repetitions per point), 2 points (long sunshine condition: princess, short sunshine condition: unsealed summer sowing, 1 repetition per point) in 2021, and 1 trial points (long sunshine condition: princess, 2 repetitions per point) in 2022, respectively, in 2015. The field traits of each strain, including silking period, pollen scattering period, maturation period, plant height and ear height, were investigated from seedling stage to maturation stage.
FIG. 8 shows the results of comparison of the number of days of pollen shed for different lines of "early 15" overexpressing transgenic maize inbred line test versus control plants. As shown in fig. 8, the 3 inbred lines in 2015 had an average 6.68 days earlier in the powder dispersion day, the 3 lines in 2020 had an average 5.61 days earlier, and the 3 lines in 2021 had an average 6.42 days earlier than the control plant ND101, all reaching very significant levels. Overall, 3 "early 15" overexpressing transgenic maize inbred lines were 15-1, 15-2 and 15-3 earlier in the number of powder days in 2015, 2020 and 2021 than the control group, and the inbred lines were 6.24 days earlier on average for the three-year trial of powder days, reaching very significant levels.
FIG. 9 shows the results of comparison of the number of days of laying of different lines in the "early 15" overexpressing transgenic maize inbred line test with control plants. As shown in fig. 9, the number of days of drawing of 3 inbred lines in 2015 was 6.78 days earlier on average, 5.35 days earlier in 2020, 6.93 days earlier in 2021, on average, than in the control plant ND101, all reaching very significant levels. Overall, 3 "early 15" overexpressing transgenic maize inbred lines were 15-1, 15-2 and 15-3 all advanced in 2015, 2020 and 2021 days of silk withdrawal over the control group, and the inbred lines were 6.36 days in average in three years of trial silk withdrawal, reaching very significant levels.
FIG. 10 shows the results of comparison of the number of days of maturity of different lines tested with the "early 15" overexpressing transgenic maize inbred line with the control plants. As shown in FIG. 10, 3 "early 15" overexpressed transgenic maize inbred lines were 9.23 days, 8.90 days earlier than the control group by the maturity days of 15-1, 15-2 and 15-3 years earlier than the control group, respectively, with an average 9.0 days earlier than the 3 inbred maturity days, reaching very significant levels.
FIG. 11 shows the results of comparison of the number of days of pollen shed for different lines of "early 15" overexpressing transgenic maize hybrid experiments with control plants. As shown in FIG. 11, the average of the number of days of pollen dispersion for 3 transgenic maize hybrids in 2015 was 7.98 days earlier and the average of the number of strains in 2021 was 6.5 days earlier than the control plants F1-ND101, all reaching very significant levels. In general, 3 'early 15' over-expressed transgenic corn hybrid F1-early 15-1, F1-early 15-2 and F1-early 15-3 are all earlier in powder scattering days in 2015 and 2021 than the control group, and the average powder scattering days of the hybrid two-year test are earlier by 7.24 days, so that the extremely remarkable level is achieved.
FIG. 12 shows the results of comparison of the number of days of laying of different lines in the "early 15" overexpressing transgenic maize hybrid test with control plants. As shown in FIG. 12, the average of 7.30 days earlier in 2015, and 7.00 days earlier in 2021, 3 lines of transgenic maize hybrids, compared to control plants F1-ND101, reached very significant levels. In general, 3 'early 15' over-expressed transgenic corn hybrids F1-early 15-1, F1-early 15-2 and F1-early 15-3 had earlier filament drawing days in 2015 and 2021 than the control group, and the average filament drawing days in two-year test of the hybrid were 7.15 days earlier, reaching a very significant level.
FIG. 13 shows the results of comparison of the number of days of maturity of different lines tested with "early 15" overexpressing transgenic maize hybrids with control plants. As shown in FIG. 13, 3 "early 15" overexpressed transgenic maize hybrids F1-early 15-1, F1-early 15-2 and F1-early 15-3 were 8.23 days, 7.90 days, and 8.0 days earlier on average than the control in the maturity period of 2022, respectively, with very significant levels.
As shown in FIG. 14, the milk line of the "early 15" overexpressing transgenic maize hybrid seed had disappeared as compared to control plants F1-ND101, and the milk line of the hybrid control plant seed had just begun.
The results show that under the conditions of long sunlight and short sunlight, the flowering phase and the maturation phase of the 'early 15' overexpression transgenic corn inbred line and the hybrid are both obviously and stably advanced (see fig. 14, 15 and 16).
3.2 Flowering phase analysis of Gene editing materials
Gene editing materials the materials used in the experiments were early 15M strain early 15M-1, early 15M-2 and early 15M-3, with ND101 as the control plant. Early 15M-1, early 15M-2, early 15M-3 and WT (ND 101) were planted in 2021 at 2 trial points (long sunshine condition: princess, short sunshine condition: kaeseen summer sowing, 1 repetition per point). The field traits of each line were investigated from seedling stage to milk stage.
FIG. 17 shows the results of comparison of the number of days of pollen shed for different lines of "early 15" gene-edited maize inbred line test with control plants. As shown in FIG. 17, 3 gene editing lines were each delayed in the days of powdering at 2021 by 15M-1, 15M-2 and 15M-3, compared to the control group. Specifically, 15M-1 was delayed 0.75 days earlier compared to the control plant ND101, which was different from the control plant ND 101. The 15M-2 and 15M-3 delays by 2.75 days and 4.75 days, respectively, compared to the control plant ND101, all reached very significant levels.
FIG. 18 shows the results of comparison of the number of days of laying of different lines in the "early 15" gene-edited maize inbred line test with control plants. As shown in FIG. 18, 3 gene-editing lines were each delayed in the days of drawing of 2021 by 15M-1, 15M-2 and 15M-3, compared to the control group. Specifically, 15M-1 was delayed 1.05 days earlier compared to the control plant ND101, which was different from the control plant ND 101. The 15M-2 and 15M-3 delays 3.55 days and 5.55 days, respectively, compared to the control plant ND101, all reached very significant levels.
The above results indicate that the flowering phase of the "early 15" gene-edited maize inbred is significantly and stably delayed under both long and short day conditions (see fig. 17, 18).
Example 4 plant height and ear position analysis of overexpressing transgenic corn of the invention
FIG. 19 shows the results of comparison of plant heights of different lines tested with "early 15" overexpressing transgenic maize inbred lines with control plants. As shown in fig. 19, the plant height of 3 inbred lines was reduced by 41.26% on average in 2015, 39.17% on average in 2020, and 34.81% on average in 2021, all at very significant levels, compared to the control plant ND 101. Overall, 3 "early 15" overexpressing transgenic maize inbred lines were each reduced in plant height by 15-1, 15-2 and 15-3 in 2015, 2020 and 2021 compared to the control group, and the three year test plant heights of the inbred lines were reduced by 38.41% on average, reaching very significant levels.
FIG. 20 shows the results of comparison of ear position of different lines with control plants in an "early 15" overexpressing transgenic maize inbred line test. As shown in fig. 20, the spike level was reduced by 69.74% on average in the 2015 3 inbred lines, 55.55% on average in the 2020 3 lines, 49.43% on average in the 2021 3 lines, all at very significant levels, compared to the control plant ND 101. Overall, 3 "early 15" overexpressing transgenic maize inbred lines were reduced in spike levels at 2015, 2020, and 2021 by 15-1, 15-2, and 3 as compared to the control group, and the inbred lines were reduced by 58.24% on average for three years of test spike levels, reaching very significant levels.
FIG. 21 shows the results of a comparison of plant heights of different lines tested on "early 15" overexpressing transgenic maize hybrids with control plants. As shown in FIG. 21, the average plant height of 3 transgenic maize hybrids was reduced by 23.98% in 2015 and 29.32% in 2021 compared to control plants F1-ND101, all reaching very significant levels. In general, the plant heights of 3 'early 15' over-expressed transgenic corn hybrid F1-early 15-1, F1-early 15-2 and F1-early 15-3 in 2015 and 2021 are reduced compared with the control group, and the average plant height of the hybrid two-year test is reduced by 26.65 percent, so that the extremely remarkable level is achieved.
FIG. 22 shows the results of a comparison of ear position of different lines of "early 15" overexpressing transgenic maize hybrids with control plants. As shown in FIG. 22, the ear position of 3 transgenic maize hybrids was reduced by 41.71% on average in 2015 and 46.79% on average in 2021 by 3 lines, all at very significant levels, compared to control plants F1-ND 101. Overall, the ears of 3 "early 15" over-expressed transgenic corn hybrids F1-early 15-1, F1-early 15-2 and F1-early 15-3 were reduced in 2015 and 2021 compared to the control, and the average ears of the hybrid two-year test were reduced by 44.25%, reaching a very significant level.
The results show that under the conditions of long sunlight and short sunlight, the plant height and the ear position of the 'early 15' overexpression transgenic corn inbred line and the hybrid are obviously and stably reduced (see fig. 15 and 16).
Reference is made to:
[1]Tapia-Lopez R,Garcia-Ponce B,Dubrovsky J G,et al..An AGAMOUS-related MADS-box gene,XAL1(AGL12),regulates root meristem cell proliferation and flowering transition in Arabidopsis[J].Plant Physiol,2008,146:1182-1192.
[2]Yoo S K,Lee J S,Ahn J H.Overexpression of AGAMOUS-LIKE 28(AGL28)promotes flowering by upregulating expression of floral promoters within the autonomous pathway[J].Biochem Bioph Res Comm,2006,348:929-936.
[3]Pelucchi N,Fornara F,Favalli C,et al..Comparative analysis of rice MADS-box genes expressed during flower development[J].Sexual Plant Reproduction,2002,15(3):113-122.
[4]Lu S J,Wei H,Wang Y,et al..Overexpression of atranscription factor OsMADS15 modifies plant architecture and flowering time in rice(Oryza sativa L.)[J].Plant Mole Bio Rep,2012,30(6):1461-1469.
[5]Alter P,Bircheneder S,Zhou L.Z,et al..Floweringtime-regulated genes in maize include the transcription factor ZmMADS1[J].Plant Physiol,2016,172:389-404.
Claims (25)
1. An isolated nucleic acid molecule comprising a sequence selected from the group consisting of:
1) A nucleotide sequence shown in SEQ ID NO. 1;
2) A nucleotide sequence with at least 85%, 90%, 91%, 92%, 93%, 94%, 95%, 96%, 97%, 98%, 99% or 99.5% identity with the nucleotide sequence shown in SEQ ID NO. 1, wherein the encoded polypeptide has the function of regulating plant growth and development;
3) A nucleotide sequence which hybridizes under stringent conditions to the sequence shown in SEQ ID No. 1;
4) Expressing the nucleotide sequence of the same or functionally deleted or mutated protein by substituting and/or deleting and/or adding one or more nucleotides in the nucleotide sequence shown in SEQ ID NO. 1;
5) Different transcripts were produced from the nucleotide sequence shown in SEQ ID No. 1.
2. An isolated nucleic acid molecule comprising a sequence selected from the group consisting of:
1) A nucleotide sequence encoding the amino acid sequence shown in SEQ ID NO. 2;
2) A nucleotide sequence encoding an amino acid sequence having at least 85%, 90%, 91%, 92%, 93%, 94%, 95%, 96%, 97%, 98%, 99% or 99.5% identity to the amino acid sequence shown in SEQ ID NO. 2, wherein the encoded polypeptide has the function of regulating plant growth;
3) A nucleotide sequence encoding an amino acid sequence obtained by substitution and/or deletion and/or addition of one or more amino acid residues in the amino acid sequence shown in SEQ ID NO. 2, and a polypeptide encoded thereby has a function of regulating plant growth and development.
3. An isolated nucleic acid molecule comprising a sequence selected from the group consisting of:
1) A nucleotide sequence shown in SEQ ID NO. 3;
2) A nucleotide sequence having at least 85%, 90%, 91%, 92%, 93%, 94%, 95%, 96%, 97%, 98%, 99% or 99.5% identity with the nucleotide sequence shown in SEQ ID NO. 3, wherein the encoded polypeptide has the function of regulating plant growth and development;
3) A nucleotide sequence which hybridizes under stringent conditions to the sequence shown in SEQ ID No. 3;
4) Expressing the nucleotide sequence of the same or functionally deleted or mutated protein by substituting and/or deleting and/or adding one or more nucleotides in the nucleotide sequence shown in SEQ ID NO. 3;
5) Different transcripts were produced from the nucleotide sequence shown in SEQ ID NO. 3.
4. An isolated polypeptide, characterized in that it is transcribed and/or expressed from the nucleic acid molecule of any one of claims 1 to 3.
5. An isolated polypeptide comprising an amino acid sequence selected from the group consisting of seq id no:
1) An amino acid sequence shown in SEQ ID NO. 2;
2) An amino acid sequence having at least 85%, 90%, 91%, 92%, 93%, 94%, 95%, 96%, 97%, 98%, 99% or 99.5% identity to the amino acid sequence shown in SEQ ID NO. 2, said polypeptide having the function of regulating plant growth;
3) The polypeptide has the function of regulating plant growth and development by substituting and/or deleting and/or adding one or more amino acid residues in the amino acid sequence shown in SEQ ID NO. 2.
6. A recombinant vector comprising the nucleic acid molecule of any one of claims 1-3.
7. A host cell comprising the nucleic acid molecule of any one of claims 1-3, or comprising the polypeptide of claim 4 or 5, or comprising the recombinant vector of claim 6.
8. A transgenic plant comprising the nucleic acid molecule of any one of claims 1-3, or comprising the recombinant vector of claim 6.
9. Transgenic plant according to claim 8, wherein the transgenic plant is a monocotyledonous or dicotyledonous plant, preferably a crop plant.
10. The transgenic plant of claim 8 or 9, wherein the transgenic plant is selected from one or more of maize, sorghum, soybean, wheat, rice, cotton, canola, cabbage, canola, mustard, barley, rye, oat, millet, tomato, sunflower, potato, peanut, sweet potato, cassava, sugar beet, sugarcane, tobacco, or arabidopsis; arabidopsis thaliana and maize are preferred.
11. Use of an isolated nucleic acid molecule according to any one of claims 1 to 3 or an isolated polypeptide according to claim 4 or 5 or a recombinant vector according to claim 6 for regulating plant growth.
12. Use of an isolated nucleic acid molecule according to any one of claims 1 to 3 or an isolated polypeptide according to claim 4 or 5 or a recombinant vector according to claim 6 for regulating early maturity and stumps in plants.
13. The use according to claim 12, comprising the steps of:
1) Introducing the nucleic acid molecule of any one of claims 1-3, or the recombinant vector of claim 6, into a plant of interest to obtain an overexpressed transgenic plant; and
2) The plants are grown such that the over-expressed transgenic plants have early maturing and dwarf performance compared to control plants.
14. Use of an isolated nucleic acid molecule according to any one of claims 1 to 3 or an isolated polypeptide according to claim 4 or 5 or a recombinant vector according to claim 6 for regulating late maturity in plants.
15. The use according to claim 14, comprising the steps of:
1) Disruption of the "early 15" gene in plants or genes homologous to the "early 15" gene in other plants to obtain transgenic plants; and
2) The plants are grown such that the transgenic plants have late-maturing properties compared to control plants.
16. The use of claim 15, wherein the disruption is achieved by knocking out or knocking down the "early 15" gene.
17. The use of claim 15, wherein the disruption is effected by a genome editing system of CRISPR/Cas, TALEN, ZFN or other gene editing system.
18. Use of an isolated nucleic acid molecule according to any one of claims 1 to 3 or an isolated polypeptide according to claim 4 or 5 or a recombinant vector according to claim 6 for breeding plants with altered traits.
19. Use according to any one of claims 11-18, wherein the plant is a monocotyledonous or dicotyledonous plant, preferably a crop plant.
20. The use according to claim 19, wherein the plant is selected from one or more of maize, sorghum, soybean, wheat, rice, cotton, canola, cabbage, canola, mustard, barley, rye, oats, millet, tomato, sunflower, potato, peanut, sweet potato, cassava, sugar beet, sugar cane, tobacco, or arabidopsis; arabidopsis thaliana and maize are preferred.
21. A method of modulating plant growth comprising:
1) Introducing the isolated nucleic acid molecule of any one of claims 1-3, or the recombinant vector of claim 6, into a plant of interest to obtain a transgenic plant; and
2) Cultivating the plant, wherein the transgenic plant has the properties of early maturing and dwarfing compared to a control plant.
22. A method of modulating plant growth comprising:
1) Disruption of the "early 15" gene in plants or genes homologous to the "early 15" gene in other plants to obtain transgenic plants; and
2) Cultivating the plant, wherein the transgenic plant has late-maturing performance compared to a control plant.
23. A method of producing a transgenic plant comprising the isolated nucleic acid molecule of any one of claims 1-3 introduced, or the recombinant vector of claim 6, or the isolated polypeptide of claim 4 or 5 expressed recombinantly, comprising the steps of:
1) Obtaining seeds of said transgenic plant;
2) Planting the seeds to obtain the transgenic plant with stable inheritable characters.
24. A method of producing a transgenic plant comprising a gene that disrupts the "early 15" gene in the plant or is homologous to the "early 15" gene in other plants, comprising the steps of:
1) Obtaining seeds of said transgenic plant;
2) Planting the seeds to obtain the transgenic plant with stable inheritable characters.
25. The method of any one of claims 21-24, wherein the plant is selected from one or more of corn, sorghum, soybean, wheat, rice, cotton, canola, cabbage, canola, mustard, barley, rye, oats, millet, tomato, sunflower, potato, peanut, sweet potato, tapioca, sugar beet, sugarcane, tobacco, or arabidopsis thaliana; arabidopsis thaliana and maize are preferred.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202211529549.0A CN118109480A (en) | 2022-11-30 | 2022-11-30 | Early 15 gene and application thereof in regulating and controlling plant growth and development |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202211529549.0A CN118109480A (en) | 2022-11-30 | 2022-11-30 | Early 15 gene and application thereof in regulating and controlling plant growth and development |
Publications (1)
Publication Number | Publication Date |
---|---|
CN118109480A true CN118109480A (en) | 2024-05-31 |
Family
ID=91212704
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN202211529549.0A Pending CN118109480A (en) | 2022-11-30 | 2022-11-30 | Early 15 gene and application thereof in regulating and controlling plant growth and development |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN118109480A (en) |
-
2022
- 2022-11-30 CN CN202211529549.0A patent/CN118109480A/en active Pending
Similar Documents
Publication | Publication Date | Title |
---|---|---|
JP6316332B2 (en) | Plant regulatory elements and uses thereof | |
CN102057045B (en) | transgenic sugar beet plants | |
EP3172225B1 (en) | Compositions and methods for increasing plant growth and yield using rice promoters | |
US20090083877A1 (en) | Transcription Factors, DNA and Methods for Introduction of Value-Added Seed Traits and Stress Tolerance | |
US10087458B2 (en) | Manipulating BS1 for plant seed yield | |
WO2013023623A1 (en) | Isolation, cloning and application of pms3, a gene for photoperiod-sensitive genic male-sterility in rice | |
RU2665804C2 (en) | Cotton phya1 rnai improving fiber quality, root elongation, flowering, maturity and yield potential in upland cultivars (gossypium hirsutum l.) | |
US20180010143A1 (en) | New rice high temperature resistance gene and use in crop breeding resistance to high temperature thereof | |
US20190177740A1 (en) | Methods and compositions for regulation of plant growth | |
WO2014069339A1 (en) | Nucleic acid imparting high-yielding property to plant, method for producing transgenic plant with increased yield, and method for increasing plant yield | |
US10072271B2 (en) | Methods for improving crop yield | |
CA2877496A1 (en) | Terminating flower (tmf) gene and methods of use | |
CN112410347A (en) | Corn ZmHsf21 gene and application thereof | |
WO2019129145A1 (en) | Flowering time-regulating gene cmp1 and related constructs and applications thereof | |
CA2978099A1 (en) | Modulation of dreb gene expression to increase maize yield and other related traits | |
CN102373217A (en) | Paddy DREBs (dehydration-responsive element binding) transcription factor and application thereof | |
US6635811B1 (en) | Pre-harvest sprouting | |
CN118109480A (en) | Early 15 gene and application thereof in regulating and controlling plant growth and development | |
CN115125259B (en) | Dwarf 20 protein, encoding gene and application thereof | |
US7179957B1 (en) | Method for altering nitrogen or oil content of seeds by down regulating AGL11 expression or activity | |
CN117187270A (en) | Corn gene ZmCPK28 and application thereof in regulating plant growth and development and environmental stress | |
US20140259224A1 (en) | Transgenic plants with enhanced traits and methods of producing thereof | |
CN116676331A (en) | Application of ZmST1 protein and coding gene thereof in regulation and control of green-keeping, disease resistance and yield of plants | |
CN114908108A (en) | Corn genes ZmCPK35, ZmCPK37 and ZmSLAC1 and application thereof in plant drought resistance | |
CN118345084A (en) | ZmEIL9 gene and protein and application thereof in regulation and control of corn kernel development |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination |